OriginClear (OCLN) 10-Q 16 Nov 21 2021 Q3 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	9 Months Ended
	Sep. 30, 2021	Nov. 15, 2021
Document Information Line Items
Entity Registrant Name	ORIGINCLEAR, INC.
Document Type	10-Q
Current Fiscal Year End Date	--12-31
Entity Common Stock, Shares Outstanding		299,793,569
Amendment Flag	false
Entity Central Index Key	0001419793
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Document Period End Date	Sep. 30, 2021
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q3
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	333-147980
Entity Incorporation, State or Country Code	NV
Entity Tax Identification Number	26-0287664
Entity Address, Address Line One	13575 58th Street North
Entity Address, Address Line Two	Suite 200
Entity Address, City or Town	Clearwater
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	33760
City Area Code	(323)
Local Phone Number	939-6645
Entity Interactive Data Current	Yes

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Sep. 30, 2021	Dec. 31, 2020
CURRENT ASSETS
Cash	$ 538,729	$ 409,591
Restricted cash	20,100	6,530
Contracts receivable	712,006	438,430
Contract assets	71,861	148,734
Inventory assets	2,850
Other receivable	2,599	3,799
Prepaid expenses	32,230	52,728
TOTAL CURRENT ASSETS	1,380,375	1,059,812
NET PROPERTY AND EQUIPMENT	224,172	258,206
OTHER ASSETS
Long term assets held for sale	514,000
Fair value investment-securities	40,000	8,000
Trademark	4,467	4,467
TOTAL OTHER ASSETS	558,467	12,467
TOTAL ASSETS	2,163,014	1,330,485
Current Liabilities
Accounts payable and other payable	932,162	1,304,803
Accrued expenses	1,524,882	1,542,816
Cumulative preferred stock dividends payable	359,267	256,274
Contract liabilities	538,706	340,551
Capital lease, current portion	9,088	9,088
Customer deposit	146,453	146,453
Warranty reserve	20,000	20,000
Loan payable, merchant cash advance	80,646	342,896
Loan payable, related party		94,883
Loans payable, SBA	150,000	505,000
Derivative liabilities	16,511,716	12,310,307
Convertible promissory notes, net of discount of $20,294 and$17,929, respectively	2,999,486	1,223,228
Total Current Liabilities	24,398,056	22,759,116
Long Term Liabilities
Capital lease, long term portion	1,169	7,985
Convertible promissory notes, net of discount of $0 and $0, respectively	62,275	1,877,275
Total Long Term Liabilities	63,444	1,885,260
Total Liabilities	24,461,500	24,644,376
COMMITMENTS AND CONTINGENCIES (See Note 11)
Total	10,128,342	6,331,409
SHAREHOLDERS’ DEFICIT
Subscription payable to purchase	100,000	100,000
Preferred treasury stock,1,000 and 1,000 shares outstanding, respectively
Common stock, $0.0001 par value, 16,000,000,000 shares authorized 225,980,190 and 65,052,688 equity shares issued and outstanding, respectively	22,598	6,505
Additional paid in capital - Common stock	73,869,508	64,265,217
Accumulated other comprehensive loss	(132)	(132)
Accumulated deficit	(106,422,106)	(94,020,294)
TOTAL SHAREHOLDERS’ DEFICIT	(32,426,828)	(29,645,300)
TOTAL LIABILITIES AND SHAREHOLDERS’ DEFICIT	2,163,014	1,330,485
Series F 8% Preferred Stock [Member]
Current Liabilities
Preferred stock value	160,000	175,000
Series F 8% Preferred Stock One [Member]
Current Liabilities
Preferred stock value	100,000	100,000
Series G 8% Preferred Stock [Member]
Current Liabilities
Preferred stock value	50,000	430,000
Series I 8% Preferred Stock
Current Liabilities
Preferred stock value	235,000	797,400
Series K 8% Preferred Stock
Current Liabilities
Preferred stock value	580,650	3,160,417
Series J Convertible Preferred Stock
Long Term Liabilities
Convertible Preferred Stock	225,000	272,500
Series L Convertible Preferred Stock
Long Term Liabilities
Convertible Preferred Stock	659,825	1,132,084
Series M Preferred Stock
Long Term Liabilities
Convertible Preferred Stock	1,009,750	1,060,325
Series O 8% Convertible Preferred Stock
Long Term Liabilities
Convertible Preferred Stock	815,000	1,995,000
Series P Convertible Preferred Stock
Long Term Liabilities
Convertible Preferred Stock	76,250	356,500
Series Q 12% Convertible Preferred Stock
Long Term Liabilities
Convertible Preferred Stock	620,000	1,025,000
Series R 10% Convertible Preferred Stock
Long Term Liabilities
Convertible Preferred Stock	4,280,017	490,000
Series S 10% Convertible Preferred Stock
Long Term Liabilities
Convertible Preferred Stock	170,000
Series T 10% Convertible Preferred Stock
Long Term Liabilities
Convertible Preferred Stock	630,000
Series U 10% Convertible Preferred Stock
Long Term Liabilities
Convertible Preferred Stock	635,000
Series W 10% Convertible Preferred Stock
Long Term Liabilities
Convertible Preferred Stock	757,500
Series X 10% Convertible Preferred Stock
Long Term Liabilities
Convertible Preferred Stock	250,000
Series C Preferred Stock
Current Liabilities
Preferred stock value
Series D-1 Preferred Stock
Current Liabilities
Preferred stock value	3,150	3,250
Series E Preferred Stock
Current Liabilities
Preferred stock value	$ 154	$ 154

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parentheticals) - USD ($)	Sep. 30, 2021	Dec. 31, 2020
Net of discount current (in Dollars)	$ 20,294	$ 17,929
Convertible promissory notes, net of discount (in Dollars)	$ 0	$ 0
Preferred treasury stock, shares outstanding	1,000	1,000
Common stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	16,000,000,000	16,000,000,000
Common stock, shares issued	225,980,190	65,052,688
Common stock, shares outstanding	225,980,190	65,052,688
Series F 8% Convertible Preferred Stock
Preferred stock, redeemable value (in Dollars)	$ 160,000	$ 175,000
Preferred stock, shares issued	160	175
Preferred stock, shares outstanding	160	175
Series F 8% Convertible Preferred Stock One
Preferred stock, redeemable value (in Dollars)	$ 100,000	$ 100,000
Preferred stock, shares issued	100	100
Preferred stock, shares outstanding	100	100
Series G 8% Convertible Preferred Stock
Preferred stock, redeemable value (in Dollars)	$ 50,000	$ 430,000
Preferred stock, shares issued	50	430
Preferred stock, shares outstanding	50	430
Series I 8% Preferred Stock
Preferred stock, redeemable value (in Dollars)	$ 235,000	$ 797,400
Preferred stock, shares issued	235	797
Preferred stock, shares outstanding	235	797
Series K 8% Preferred Stock
Preferred stock, redeemable value (in Dollars)	$ 580,650	$ 3,160,417
Preferred stock, shares issued	581	3,160
Preferred stock, shares outstanding	581	3,160
Series J Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 225,000	$ 272,500
Convertible preferred stock, shares issued	225	273
Convertible preferred stock, shares outstanding	225	273
Series L Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 659,825	$ 1,132,084
Convertible preferred stock, shares issued	659.8	1,132
Convertible preferred stock, shares outstanding	659.8	1,132
Series M Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 1,009,750	$ 1,060,325
Convertible preferred stock, shares issued	40,340	42,213
Convertible preferred stock, shares outstanding	40,340	42,213
Series O 8% Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 815,000	$ 1,995,000
Convertible preferred stock, shares issued	815	1,995
Convertible preferred stock, shares outstanding	815	1,995
Series P Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 76,250	$ 356,500
Convertible preferred stock, shares issued	76	357
Convertible preferred stock, shares outstanding	76	357
Series Q 12% Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 620,000	$ 1,025,000
Convertible preferred stock, shares issued	620	1,025
Convertible preferred stock, shares outstanding	620	1,025
Series R 10% Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 4,280,017	$ 490,000
Convertible preferred stock, shares issued	4,280	490
Convertible preferred stock, shares outstanding	4,280	490
Series S 10% Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 170,000	$ 0
Convertible preferred stock, shares issued	170	0
Convertible preferred stock, shares outstanding	170	0
Series T 10% Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 630,000	$ 0
Convertible preferred stock, shares	630	0
Series U 10% Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 635,000	$ 0
Convertible preferred stock, shares issued	635	0
Convertible preferred stock, shares outstanding	635	0
Series W 10% Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 757,500	$ 0
Convertible preferred stock, shares issued	757.5	0
Convertible preferred stock, shares outstanding	757.5	0
Series X 10% Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 250,000	$ 0
Convertible preferred stock, shares	250	0
Series C Preferred Stock
Preferred stock, shares issued	1,000	1,000
Preferred stock, shares outstanding	1,000	1,000
Preferred stock value (in Dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	550,000,000	550,000,000
Series D-1 Preferred Stock
Preferred stock, shares issued	31,500,000	32,500,000
Preferred stock, shares outstanding	31,500,000	31,500,000
Series E Preferred Stock
Preferred stock, shares issued	1,537,213	1,537,213
Preferred stock, shares outstanding	1,537,213	1,537,213

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Income Statement [Abstract]
Sales	$ 1,120,687	$ 917,320	$ 2,848,287	$ 3,064,758
Cost of Goods Sold	790,336	934,708	2,237,282	2,716,582
Gross Profit	330,351	(17,388)	611,005	348,176
Operating Expenses
Selling and marketing expenses	636,481	339,759	2,201,045	1,053,559
General and administrative expenses	1,006,041	782,810	2,785,713	1,853,760
Research and development		29,334		83,400
Depreciation and amortization expense	10,903	14,431	34,034	39,892
Total Operating Expenses	1,653,425	1,166,334	5,020,792	3,030,611
Loss from Operations	(1,323,074)	(1,183,722)	(4,409,787)	(2,682,435)
OTHER INCOME (EXPENSE)
Other income	356,438	4,001	359,939	12,521
Impairment of asset for sale	(116,000)		(116,000)
Gain on write off loans payable	151,000		157,250
Gain/(Loss) on conversion of preferred stock	(146,382)	18,066	(1,265,666)	24,129
Loss on exchange of preferred stock			(40,000)
Unrealized gain(loss) on investment securities	(8,400)	3,600	32,000	400
Gain on net change in derivative liability and conversion of debt	19,798,080	6,409,231	(4,146,757)	23,627,793
Interest expense	(314,547)	(233,010)	(934,942)	(638,077)
TOTAL OTHER (EXPENSE) INCOME	19,720,189	6,201,888	(5,954,176)	23,026,766
NET INCOME (LOSS)	18,397,115	5,018,166	(10,363,963)	20,344,331
PREFERRED STOCK DIVIDENDS
WARRANTS DEEMED DIVIDENDS			(2,037,849)
NET (LOSS) ATTRIBUTABLE TO SHAREHOLDERS INCOME	$ 18,397,115	$ 5,018,166	$ (12,401,812)	$ 20,344,331
BASIC EARNINGS (LOSS) PER SHARE ATTRIBUTABLE TO SHAREHOLDERS’ (in Dollars per share)	$ 0.09	$ 0.27	$ (0.08)	$ 1.75
DILUTED EARNINGS (LOSS) PER SHARE ATTRIBUTABLE TO SHAREHOLDERS’ (in Dollars per share)	$ 0.02	$ 0.03	$ (0.08)	$ 0.15
WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING, BASIC (in Shares)	197,669,804	18,643,531	147,762,596	11,598,453
DILUTED (in Shares)	795,174,058	146,074,997	147,762,596	139,029,918

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Shareholders' Deficit - USD ($)	Preferred stock	Common stock	Additional Paid-in-Capital	Subscription Payable	Accumulated Other Comprehensive loss	Accumulated Deficit	Mezzanine Equity	Total
Balance at Dec. 31, 2019	$ 4,067	$ 486	$ 64,915,364		$ (134)	$ (107,281,659)	$ 2,204,025	$ (42,361,876)
Balance (in Shares) at Dec. 31, 2019	40,674,799	4,854,993
Rounding	$ 1	$ (1)
Common stock issuance for conversion of debt and accrued interest		$ 973	277,197					278,171
Common stock issuance for conversion of debt and accrued interest (in Shares)		9,732,328
Common stock issued at fair value for services		$ 330	263,667					263,997
Common stock issued at fair value for services (in Shares)		3,297,275
Common stock issued for conversion of Series D1 Preferred stock	$ (600)	$ 30	24,348					23,778
Common stock issued for conversion of Series D1 Preferred stock (in Shares)	(6,000,000)	295,141
Common stock issued for conversion of Series E Preferred stock	$ (60)	$ 3	57
Common stock issued for conversion of Series E Preferred stock (in Shares)	(602,436)	30,124
Common stock issued for conversion of Series J Preferred stock		$ 231	(231)				(69,700)
Common stock issued for conversion of Series J Preferred stock (in Shares)	(70)	2,313,689
Common stock issued for conversion of Series L Preferred stock		$ 1,004	(1,004)				285,675
Common stock issued for conversion of Series L Preferred stock (in Shares)	(295)	10,038,055
Common stock issued for conversion of Series M Preferred stock		$ 14	(14)				135,400
Common stock issued for conversion of Series M Preferred stock (in Shares)	(320)	137,052
Common stock issued for conversion of Series O Preferred stock		$ 17	(17)				1,245,000
Common stock issued for conversion of Series O Preferred stock (in Shares)		166,990
Common stock issued for conversion of Series P Preferred stock		$ 57	(57)				301,000
Common stock issued for conversion of Series P Preferred stock (in Shares)	(10)	570,475
Issuance of Series M Preferred stock through a private placement			145,250	5,000			155,250	150,250
Exchange of Series F Preferred stock to Series Q Preferred stock							1,188,000
Reclassification of non-cash adjustment			(46,260)					(46,260)
Reclassification of preferred stock	$ (4)
Reclassification of preferred stock (in Shares)	(34,455)
Reclassification from equity to mezzanine			(2,856,397)					(2,856,397)
Gain on conversion of Series L Preferred stock			(24,129)					(24,129)
Subscription payable-common stock				100,000				100,000
Comprehensive gain					1			1
Net Income (loss)						20,344,331		20,344,331
Balance at Sep. 30, 2020	$ 3,404	$ 3,144	62,697,774	105,000	(133)	(86,937,328)	5,289,400	(24,128,134)
Balance (in Shares) at Sep. 30, 2020	34,037,213	31,436,122
Balance at Dec. 31, 2020	$ 3,404	$ 6,505	64,265,217	100,000	(132)	(94,020,294)	6,331,409	(29,645,300)
Balance (in Shares) at Dec. 31, 2020	34,038,213	65,052,688
Rounding		$ (2)	(1)					(3)
Common stock issuance for conversion of debt and accrued interest		$ 1,393	132,312					133,705
Common stock issuance for conversion of debt and accrued interest (in Shares)		13,927,622
Common stock issued at fair value for services		$ 2,466	1,927,258					1,929,724
Common stock issued at fair value for services (in Shares)		24,656,117
Common stock issued for conversion of Series D1 Preferred stock	$ (100)	$ 7	5,547					5,454
Common stock issued for conversion of Series D1 Preferred stock (in Shares)	(1,000,000)	68,571
Common stock issued for conversion of Series J Preferred stock		$ 120	47,380				(47,500)	47,500
Common stock issued for conversion of Series J Preferred stock (in Shares)		1,203,924
Common stock issued for conversion of Series L Preferred stock		$ 1,527	471,232				(472,759)	472,759
Common stock issued for conversion of Series L Preferred stock (in Shares)		15,265,754
Common stock issued for Series O Preferred stock dividends		$ 50	(50)
Common stock issued for Series O Preferred stock dividends (in Shares)		495,366
Common stock issued for conversion of Series O Preferred stock		$ 2,736	1,057,264				(1,060,000)	1,060,000
Common stock issued for conversion of Series O Preferred stock (in Shares)		27,357,198
Common stock issued for conversion of Series P Preferred stock		$ 909	279,341				(280,250)	280,250
Common stock issued for conversion of Series P Preferred stock (in Shares)		9,086,985
Common stock issued for conversion of Series Q Preferred stock		$ 1,067	418,933				(420,000)	420,000
Common stock issued for conversion of Series Q Preferred stock (in Shares)		10,668,656
Common stock issued for conversion of Series R Preferred stock		$ 3,352	1,081,548				(1,084,900)	1,084,900
Common stock issued for conversion of Series R Preferred stock (in Shares)		33,520,261
Common stock issued for conversion of Series S Preferred stock		$ 550	194,450				(195,000)	195,000
Common stock issued for conversion of Series S Preferred stock (in Shares)		5,495,406
Common stock issued in conjunction with the sale of Series X Preferred stock		$ 180	(180)
Common stock issued in conjunction with the sale of Series X Preferred stock (in Shares)		1,798,562
Common stock issued for conversion of Series U Preferred stock		$ 873	329,127				(330,000)	330,000
Common stock issued for conversion of Series U Preferred stock (in Shares)		8,729,034
Common stock issued for conversion of Series W Preferred stock		$ 702	244,798				(245,500)	245,500
Common stock issued for conversion of Series W Preferred stock (in Shares)		7,020,764
Common stock issued for make good shares for Series P Preferred Stock		$ 63	(63)
Common stock issued for make good shares for Series P Preferred Stock (in Shares)		633,282
Issuance of Series M Preferred stock through a private placement							29,425
Issuance of Series R Preferred stock through a private placement							2,480,750
Exercise of warrants purchased for cash		$ 100	49,900					50,000
Exercise of warrants purchased for cash (in Shares)		1,000,000
Issuance of Series T Preferred stock in exchange for property							630,000
Issuance of Series U Preferred stock through a private placement							965,000
Issuance of Series X Preferred stock through a private placement							250,000
Exchange of Series F Preferred Stock for Series Q Preferred stock							15,000
Exchange of Series G Preferred Stock for Series R Preferred stock							15,000
Exchange of Series G Preferred Stock for Series S Preferred stock							365,000
Exchange of Series I Preferred Stock for Series R Preferred stock							317,400
Exchange of Series I Preferred Stock for Series W Preferred stock							245,000
Exchange of Series K Preferred Stock for Series R Preferred stock							1,821,767
Exchange of Series K Preferred Stock for Series W Preferred stock							758,000
Exchange of Series M Preferred Stock for Series R Preferred stock							40,000
Loss on issuance of Preferred Stock			125,000					125,000
Loss on conversion of Preferred Stock			1,140,666					1,140,666
Adjustment to Series L Preferred stock			(500)				500	(500)
Issuance of common stock warrants deemed dividends			2,037,849			(2,037,849)
Stock based compensation			62,480					62,480
Net Income (loss)						(10,363,963)		(10,363,963)
Balance at Sep. 30, 2021	$ 3,304	$ 22,598	$ 73,869,508	$ 100,000	$ (132)	$ (106,422,106)	$ 10,128,342	$ (32,426,828)
Balance (in Shares) at Sep. 30, 2021	33,038,213	225,980,190

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Income (loss)	$ (10,363,963)	$ 20,344,331
Adjustment to reconcile net loss to net cash used in operating activities
Depreciation and amortization	34,034	39,892
Stock compensation expense	62,480
Common and preferred stock issued for services	1,929,724	287,775
(Gain) Loss on net change in valuation of derivative liability	4,146,757	(23,627,793)
Debt discount recognized as interest expense	52,288
Net unrealized (gain)loss on fair value of security	(32,000)	(400)
Loss on exchange of preferred stock	40,000
Loss on issuance of preferred stock	125,000
SBA loans forgiven	(355,000)
Impairment of assets held for sale	116,000
(Gain) Loss on conversion of preferred stock	1,140,666	(24,129)
(Gain) on write off of other payables	(157,250)
Interest receivable on convertible note receivable		(12,000)
Change in Assets (Increase) Decrease in:
Contracts receivable	(273,576)	19,432
Contract asset	76,873	25,880
Inventory asset	(2,850)
Prepaid expenses and other assets	20,498	13,831
Other receivable	1,200
Change in Liabilities Increase (Decrease) in:
Accounts payable	(372,641)	79,454
Accrued expenses	53,572	180,606
Contract liabilities	198,155	26,672
Customer deposit		9,688
NET CASH USED IN OPERATING ACTIVITIES	(3,560,033)	(2,636,761)
CASH FLOWS USED FROM INVESTING ACTIVITIES:
Purchase of fixed assets	(13,500)	(9,386)
NET CASH USED IN INVESTING ACTIVITIES	(13,500)	(9,386)
CASH FLOWS FROM FINANCING ACTIVITIES:
Payments on capital lease	(6,816)	(6,816)
Proceeds from SBA loans		510,000
Repayment of loans, net	(105,000)	(84,318)
Repayment of loans, related party, net	(94,883)	(68,038)
Net payments on cumulative preferred stock dividends payable	102,993	112,732
Payoff on convertible promissory notes	(15,228)
Proceeds for the purchase of warrants	50,000
Net proceeds for issuance of preferred stock for cash - mezzanine classification	3,725,175	150,250
Net proceeds for issuance of preferred stock for cash – liability classification		2,299,668
Proceeds from convertible notes	60,000
NET CASH PROVIDED BY FINANCING ACTIVITIES	3,716,241	2,913,478
NET INCREASE IN CASH	142,708	267,331
CASH BEGINNING OF PERIOD	416,121	490,614
CASH END OF PERIOD	558,829	757,945
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Interest paid	3,741	19,108
Taxes paid
SUPPLEMENTAL DISCLOSURES OF NON CASH TRANSACTIONS
Common stock issued at fair value for conversion of debt, plus accrued interest, and other fees	133,705	278,170
Other payable for fixed asset with common stock subscription		184,000
Issuance of Series T preferred shares in exchange for property	630,000
Issuance of Series O dividends	50
Preferred stock converted to common stock	4,135,909	1,308
Exchange from mezzanine to liability	3,537,167
Warrants deemed dividends	2,037,849
Derivative discount issued on notes payable	54,652
Reclassification of non-cash adjustment of preferred stock additional paid in capital		$ (46,260)

Organization and Line of Busine

Organization and Line of Business	9 Months Ended
	Sep. 30, 2021
Accounting Policies [Abstract]
ORGANIZATION AND LINE OF BUSINESS	1. The accompanying unaudited condensed consolidated financial statements of OriginClear, Inc. (the “Company”) have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all normal recurring adjustments considered necessary for a fair presentation have been included. Operating results for the nine months ended September 30, 2021 are not necessarily indicative of the results that may be expected for the year ending December 31, 2021. For further information refer to the financial statements and footnotes thereto included in the Company’s Form 10-K for the year ended December 31, 2020. We have taken initial steps in a new direction implementing Water On Demand (‘WOD’) as a potential revenue source. The WOD model intends to offer private businesses the ability to pay for their water treatment and purification services on a pay-per-gallon basis. In the water industry, this is commonly known as Design-Build-Own-Operate or DBOO. On April 13, 2021, we announced formation of a wholly-owned subsidiary called Water On Demand #1, Inc. (WOD #1) to pursue capitalization of the equipment required. Our current plan is to pursue a first DBOO contract as a use case, and thereafter either develop, contract or acquire the O&M capability. WOD requires both funding for WOD #1, and such a first client, to launch commercially. On October 29, 2021, the Company received initial funding for WOD #1 and began talks with a prospective client for a pilot DBOO project. During the nine month period ended September 30, 2021, the Company ventured into acquiring real estate assets to finance water projects. An OriginClear advisor and founder of strategic partner PhilanthroInvestors Inc. invested certain real estate assets through an asset purchase agreement. Per the asset purchase agreement, in exchange for preferred stock and warrants, the Company received real property. The real property has been listed actively on the market to be sold. On September 13, 2021, the Company received an offer for the residential property for $464,000. The offer was accepted and the Company is currently completing all formalities required to close the transaction (refer note 3 - Series T). We intend to apply the proceeds received from the sale of the real property to finance water systems either in support of standard equipment sales by our subsidiary Progressive Water Treatment (“PWT”), or for the newer Water On Demand pre-funded water systems, or any combination thereof. Going Concern The accompanying financial statements have been prepared on a going concern basis of accounting, which contemplates continuity of operations, realization of assets and liabilities and commitments in the normal course of business. The accompanying financial statements do not reflect any adjustments that might result if the Company is unable to continue as a going concern. These factors, among others raise substantial doubt about the Company’s ability to continue as a going concern. Our independent auditors, in their report on our audited financial statements for the year ended December 31, 2020 expressed substantial doubt about our ability to continue as a going concern. The ability of the Company to continue as a going concern and appropriateness of using the going concern basis is dependent upon, among other things, achieving profitable operations and receiving additional cash infusions. During the nine months ended September 30, 2021, the Company obtained funds from sales of its preferred stock. Management believes this funding will continue from its current investors and from new investors. The Company also generated revenue of $2,848,287 and has standing purchase orders and open invoices with customers which will provide funds for operations (Refer paragraph OTG Milestones under the business overview section of the Management Discussion and Analysis – PWT and Modular Water Systems). Management believes existing shareholders, prospective new investors and future sales will provide the additional cash needed to meet the Company’s obligations as they become due and will allow the development of its core business operations. No assurance can be given that any future financing will be available or, if available, that it will be on terms that are satisfactory to the Company. Even if the Company is able to obtain additional financing, it may contain restrictions on our operations, in the case of debt financing or cause substantial dilution for our stockholders, in case of equity financing.

Summary of Significant Accounti

Summary of Significant Accounting Polices	9 Months Ended
	Sep. 30, 2021
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICES	2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICES This summary of significant accounting policies of the Company is presented to assist in understanding the Company’s financial statements. The financial statements and notes are representations of the Company’s management, which is responsible for their integrity and objectivity. These accounting policies conform to accounting principles generally accepted in the United States of America and have been consistently applied in the preparation of the financial statements. Principles of Consolidation The accompanying consolidated financial statements include the accounts of OriginClear, Inc. and its wholly owned operating subsidiaries, Progressive Water Treatment, Inc., and OriginClear Technologies, Ltd. All material intercompany transactions have been eliminated upon consolidation of these entities. Cash and Cash Equivalent The Company considers all highly liquid investments with an original maturity of six months or less to be cash equivalents. Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include estimates used to review the Company’s impairments and estimations of long-lived assets, revenue recognition on percentage of completion type contracts, allowances for uncollectible accounts, warranty reserves, inventory valuation, derivative liabilities and other conversion features, fair value investments, valuations of non-cash capital stock issuances and the valuation allowance on deferred tax assets. The Company bases its estimates on historical experience and on various other assumptions that the Company believes to be reasonable in the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. Net Earnings (Loss) per Share Calculations Basic loss per share calculations are computed by dividing income (loss) available to common shareholders by the weighted-average number of common shares available. Diluted earnings per share is computed similar to basic earnings per share except that the denominator is increased to include securities or other contracts to issue common stock that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. The Company’s diluted loss per share is the same as the basic loss per share for the nine months ended September 30, 2021, as the inclusion of any potential shares would have had an anti-dilutive effect due to the Company generating a loss. For the Nine months Ended 2021 2020 (Loss) Income to common shareholders (Numerator) $ (12,401,812 ) $ 20,344,331 Basic weighted average number of common shares outstanding (Denominator) 147,762,596 11,598,453 Diluted weighted average number of common shares outstanding (Denominator) 147,762,596 139,029,918 The Company excludes issuable shares from warrants, convertible notes and preferred stock, if their impact on the loss per share is anti-dilutive and includes the issuable shares if their impact is dilutive. September 30, 2021 Anti-dilutive Dilutive Warrant shares 215,478,283 Convertible debt shares 11,460,000 381,025,971 Preferred shares 33,037,213 - September 30, 2020 Warrant shares 122,044 - Convertible debt shares 17,954,000 262,076,475 Preferred shares 34,037,213 - Revenue Recognition We recognize revenue when services are performed, and at the time of shipment of products, provided that evidence of an arrangement exists, title and risk of loss have passed to the customer, fees are fixed or determinable, and collection of the related receivable is reasonably assured. Revenues and related costs on construction contracts are recognized as the performance obligations for work are satisfied over time in accordance with Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers. Under ASC 606, revenue and associated profit, will be recognized as the customer obtains control of the goods and services promised in the contract (i.e., performance obligations). All un-allocable indirect costs and corporate general and administrative costs are charged to the periods as incurred. However, in the event a loss on a contract is foreseen, the Company will recognize the loss as it is determined. Revisions in cost and profit estimates during the course of the contract are reflected in the accounting period in which the facts for the revisions become known. Provisions for estimated losses on uncompleted contracts are made in the period in which such losses are determined. Changes in job performance, job conditions, and estimated profitability, including those arising from contract penalty provisions, and final contract settlements, may result in revisions to costs and income, which are recognized in the period the revisions are determined. Contract receivables are recorded on contracts for amounts currently due based upon progress billings, as well as retention, which are collectible upon completion of the contracts. Accounts payable to material suppliers and subcontractors are recorded for amounts currently due based upon work completed or materials received, as are retention due subcontractors, which are payable upon completion of the contract. General and administrative expenses are charged to operations as incurred and are not allocated to contract costs. Contract Receivable The Company bills its customers in accordance with contractual agreements. The agreements generally require billing to be on a progressive basis as work is completed. Credit is extended based on evaluation of clients financial condition and collateral is not required. The Company maintains an allowance for doubtful accounts for estimated losses that may arise if any customer is unable to make required payments. Management performs a quantitative and qualitative review of the receivables past due from customers on a monthly basis. The Company records an allowance against uncollectible items for each customer after all reasonable means of collection have been exhausted, and the potential for recovery is considered remote. There was no allowance for doubtful accounts as of September 30, 2021 and December 31, 2020, respectively. The net contract receivable balance was $712,006 and $438,430 at September 30, 2021 and December 31, 2020, respectively. Indefinite Lived Intangibles and Goodwill Assets The Company accounts for business combinations under the acquisition method of accounting in accordance with ASC 805, “Business Combinations,” where the total purchase price is allocated to the tangible and identified intangible assets acquired and liabilities assumed based on their estimated fair values. The purchase price is allocated using the information currently available, and may be adjusted, up to one year from acquisition date, after obtaining more information regarding, among other things, asset valuations, liabilities assumed and revisions to preliminary estimates. The purchase price in excess of the fair value of the tangible and identified intangible assets acquired less liabilities assumed is recognized as goodwill. The Company tests for indefinite lived intangibles and goodwill impairment in the fourth quarter of each year and whenever events or circumstances indicate that the carrying amount of the asset exceeds its fair value and may not be recoverable. In accordance with its policies, the Company performed a qualitative assessment of indefinite lived intangibles at September 30, 2021 and December 31, 2020, and determined there was no impairment of indefinite lived intangibles and goodwill. Research and Development Research and development costs are expensed as incurred. Total research and development costs were $0 and $83,400 for the nine months ended September 30, 2021 and 2020, respectively. Advertising Costs The Company expenses the cost of advertising and promotional materials when incurred. The advertising costs were $114,673 and $116,951 for the nine months ended September 30, 2021 and 2020, respectively. Property and Equipment Property and equipment are stated at cost. Gain or loss is recognized upon disposal of property and equipment, and the asset and related accumulated depreciation are removed from the accounts. Expenditures for maintenance and repairs are charged to expense as incurred, while expenditures for addition and betterment are capitalized. Furniture and equipment are depreciated on the straight-line method and include the following categories: Estimated Life Machinery and equipment 5-10 years Furniture, fixtures and computer equipment 5-7 years Vehicles 3-5 years Leasehold improvements 2-5 years Long-lived assets held and used by the Company are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. In the event that facts and circumstances indicate that the cost of any long-lived assets may be impaired, an evaluation of recoverability would be performed following generally accepted accounting principles. Depreciation expense during the nine months ended September 30, 2021 and 2020, was $34,034 and $39,892, respectively. Inventory The Company expenses inventory on a first in, first out basis, and had raw materials of $2,850 and $0 as of September 30, 2021 and December 31, 2020, respectively. Stock-Based Compensation The Company periodically issues stock options and warrants to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for stock option and warrant grants issued and vesting to employees based on the authoritative guidance provided by the Financial Accounting Standards Board whereas the value of the award is measured on the date of grant and recognized over the vesting period. The Company accounts for stock option and warrant grants issued and vesting to non-employees in accordance with the authoritative guidance of the Financial Accounting Standards Board whereas the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges generally are amortized over the vesting period on a straight-line basis. In certain circumstances where there are no future performance requirements by the non-employee, option grants are immediately vested and the total stock-based compensation charge is recorded in the period of the measurement date. Accounting for Derivatives The Company evaluates all of its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a probability weighted average series Binomial lattice option pricing models to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date. Fair Value of Financial Instruments Fair Value of Financial Instruments, requires disclosure of the fair value information, whether or not recognized in the balance sheet, where it is practicable to estimate that value. As of September 30, 2021, the balances reported for cash, contract receivables, cost in excess of billing, prepaid expenses, accounts payable, billing in excess of cost, and accrued expenses approximate the fair value because of their short maturities. We adopted ASC Topic 820 for financial instruments measured as fair value on a recurring basis. ASC Topic 820 defines fair value, established a framework for measuring fair value in accordance with accounting principles generally accepted in the United States and expands disclosures about fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 established a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include: ● Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. The following table presents certain investments and liabilities of the Company’s financial assets measured and recorded at fair value on the Company’s balance sheets on a recurring basis and their level within the fair value hierarchy as of September 30, 2021. Total (Level 1) (Level 2) (Level 3) Investment at fair value-securities $ 40,000 $ 40,000 $ - $ - Total Assets measured at fair value $ 40,000 $ 40,000 $ - $ - Total (Level 1) (Level 2) (Level 3) Derivative Liability, September 30, 2021 $ 16,511,716 $ - $ - $ 16,511,716 Total liabilities measured at fair value $ 16,511,716 $ - $ - $ 16,511,716 The following is a reconciliation of the derivative liability for which level 3 inputs were used in determining the approximate fair value: Balance as of January 1, 2021 $ 12,310,307 Fair value at issuance 54,652 Loss on conversion of debt and change in derivative liability 4,146,757 Balance as of September 30, 2021 $ 16,511,716 For purpose of determining the fair market value of the derivative liability, the Company used Binomial lattice formula valuation model. The significant assumptions used in the Binomial lattice formula valuation of the derivative are as follows: 9/30/2021 Risk free interest rate .05% - .28% Stock volatility factor 43.0% - 182.0% Weighted average expected option life 0 months - 5 years Expected dividend yield None Segment Reporting The Company’s business currently operates in one segment based upon the Company’s organizational structure and the way in which the operations are managed and evaluated. Marketable Securities The Company adopted ASU 2016-01, “Financial Instruments – Recognition and Measurement of Financial Assets and Financial Liabilities.” ASU 2016-01 requires investments (except those accounted for under the equity method of accounting, or those that result in consolidation of the investee) to be measured at fair value with changes in fair value recognized in net income. It requires public business entities to use the exit price notion when measuring the fair value of financial instruments for disclosure purpose, and separate presentation of financial assets and financial liabilities by measurement category and form of financial asset. It eliminates the requirement for public business entities to disclose the method(s) and significant assumptions used to estimate the fair value that is required to be disclosed for financial instruments measured at amortized cost. The Company has evaluated the potential impact this standard may have on the condensed consolidated financial statements and determined that it had a significant impact on the condensed consolidated financial statements. The Company accounts for its investment in Water Technologies International, Inc. as available-for-sale securities, and the unrealized gain on the available-for-sale securities is recognized in net income. Licensing agreement The Company analyzed the licensing agreement using ASU 606 to determine the timing of revenue recognition. The licensing of the intellectual property (IP) is distinct from the non-license goods or services and has significant standalone functionality that provides a benefit or value. The functionality will not change during the license period due to the licensor’s activities. Because the significant standalone functionality is delivered immediately, the revenue is generally recognized when the license is delivered. Recently Issued Accounting Pronouncements In August 2017, FASB issued accounting standards update ASU-2017-12, “D” (Topic 815) – “Targeted Improvements to Accounting for Hedging Activities”, to require an entity to present the earnings effect of the hedging instrument in the same statement line item in which the earnings effect of the hedged item is reported. The amendments in this update are effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2019, and interim periods with the fiscal years beginning after December 15, 2020. Early adoption is permitted in any interim period after issuance of the update. The Company has evaluated the impact of the adoption of ASU 2017-12 on the Company’s audited consolidated financial statements, which had no material impact. In September 2018, FASB issued accounting standards update ASU 2018-07, (Topic 505) – “Shared-Based Payment Arrangements with Nonemployees”, which simplifies the accounting for share-based payments granted to nonemployees for goods and services. Under the ASU, most of the guidance on such payments to nonemployees will be aligned with the requirements for share-based payments granted to employees. Under the ASU 2018-07, the measurement of equity-classified nonemployee share-based payments will be fixed on the grant date, as defined in ASC 718, and will use the term nonemployee vesting period, rather than requisite service period. The amendments in this update are effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. Early adoption is permitted if financial statements have not yet been issued. The Company adopted ASU 2018-07 on the January 1, 2019. The adoption of the new standard did not have a material impact on the Company’s condensed consolidated financial statements. Management reviewed currently issued pronouncements and does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the accompanying condensed financial statements.

Capital Stock

Capital Stock	9 Months Ended
	Sep. 30, 2021
Stockholders' Equity Note [Abstract]
CAPITAL STOCK	3. CAPITAL STOCK Preferred Stock Series C On March 14, 2017, the Board of Directors authorized the issuance of 1,000 shares of Series C preferred stock, to T. Riggs Eckelberry in exchange for his continued employment with the Company. The holder of Series C preferred stock is not entitled to receive dividends, is not entitled to any liquidation preference and shares of Series C preferred stock do not have any conversion rights. The Series C preferred stock entitles the holder to 51% of the total voting power of our stockholders. The purchase price of the Series C preferred stock was $0.0001 per share representing a total purchase price of $0.10 for 1,000 shares. As of September 30, 2021, there were 1,000 shares of Series C preferred stock outstanding held by Mr. Eckelberry. Series D-1 On April 13, 2018, the Company designated 50,000,000 shares of its authorized preferred stock as Series D-1 preferred stock. The shares of Series D-1 preferred stock are not entitled to dividends and do not have a liquidation preference. Each share of Series D-1 preferred stock is convertible into 0.0005 of one share of common stock. The Series D-1 preferred stock may not be converted to common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of our outstanding common stock, which amount may be increased to 9.99% at the holder’s discretion upon 61 days’ written notice. During the nine months ended September 30, 2021, the Company issued 68,571 shares of common stock upon conversion of 1,000,000 shares of Series D-1 preferred stock. There was no gain or loss on the conversion. As of September 30, 2021, there were 31,500,000 shares of Series D-1 preferred stock issued and outstanding. Series E On August 14, 2018, the Company designated 4,000,000 shares of its authorized preferred stock as Series E preferred stock. The shares of Series E preferred stock are not entitled to dividends and do not have a liquidation preference. Each share of Series E preferred stock is convertible into 0.05 shares of common stock. The shares of Series E preferred stock do not have any voting rights. The Series E preferred stock may not be converted to common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of our outstanding common stock, which amount may be increased to 9.99% at the holder’s discretion upon 61 days’ written notice. As of September 30, 2021, there were 1,537,213 shares of Series E preferred stock issued and outstanding. Series F On August 14, 2018, the Company designated 6,000 shares as Series F preferred stock. The shares of Series F preferred stock have a liquidation preference equal to the stated value of $1,000 per share plus any accrued but unpaid dividends. The Series F preferred stock is not convertible into common stock. The holders of outstanding shares of Series F preferred stock are entitled to quarterly dividends at the annual rate of 8% of the stated value, in preference to any dividends on the common stock. The shares of Series F preferred stock do not have any voting rights. The Company may, in its sole discretion, at any time while the Series F preferred stock is outstanding, redeem all or any portion of the outstanding Series preferred stock at a price equal to the stated value, plus any accrued but unpaid dividends. The Company was required to redeem all outstanding shares of Series F preferred stock on September 1, 2020. During the year ended December 31, 2020, the Company exchanged 1,278 shares of Series F preferred stock for 1,278 shares of Series Q preferred stock. On October 19, 2020, 125 shares of Series F preferred stock were exchanged for 125 shares of Series O preferred stock and 31 shares of Series P preferred stock. As of December 31, 2020, there were 275 shares of Series F preferred stock issued and outstanding. As of December 31, 2020, a holder of 100 of such outstanding shares of Series F preferred stock, agreed that the Company would have no obligation to redeem such holder’s shares of Series F preferred stock prior to September 1, 2022, and the Company agreed to pay such holder, in addition to any dividends payable on such holder’s Series F preferred stock, an annual fee of 4% of the stated value of such holder’s shares of Series F preferred stock. During the nine months ended September 30, 2021, 15 shares of Series F preferred stock were exchanged for 15 shares of Series Q preferred stock and no gain or loss was recognized Excluding the 100 shares mentioned above, as of September 30, 2021, the Company had 160 outstanding shares of Series F preferred stock which the Company was required to, and failed to redeem on September 1, 2020, and was in default for an aggregate redemption price (equal to the stated value) of $160,000. Series G On January 16, 2019, the Company designated 6,000 shares as Series G preferred stock, each share having a stated value of $1,000 per share and holders of Series G preferred stock are entitled to cumulative dividends at the annual rate of 8% of the stated value, payable quarterly. The Series G preferred stock does not have voting rights, except as required by law and is not convertible into common stock. The Company may, in its sole discretion, at any time while the Series G preferred stock is outstanding, redeem all or any portion of the outstanding Series G preferred stock at a price equal to the stated value plus any accrued but unpaid dividends. The Company was required to redeem such shares of Series G preferred stock on April 30, 2021, at a price equal to the stated value plus any accrued but unpaid dividends. Pursuant to certain subscription agreements entered into with purchasers of the Series G preferred stock, each purchaser received shares of the Company’s common stock equal to an amount of, for each share of Series G preferred stock purchased, five hundred dollars ($500) divided by the closing price on the date the Company receives the executed subscription documents and purchase price from such investor. During the nine months ended September 30, 2021, 380 shares of Series G preferred stock were exchanged for 365 shares of Series S preferred stock, and 15 shares of Series R preferred stock. The shares were issued and exchanged within the terms of the agreement and no gain or loss was recognized. As of September 30, 2021, there were 50 shares of Series G preferred stock issued and outstanding which the Company was required to, and failed to redeem on April 30, 2021, for an aggregate redemption price (equal to the stated value) of $50,000. Series I On April 3, 2019, the Company designated 4,000 shares of preferred stock as Series I. The Series I has a stated value of $1,000 per share. Series I holders are entitled to cumulative dividends at the annual rate of 8% of the stated value, payable quarterly within 60 days from the end of each fiscal quarter. The Series I are not entitled to any voting rights except as may be required by applicable law, and are not convertible into common stock. The Company has the right to redeem the Series I at any time while the Series I are outstanding at a price equal to the stated value plus any accrued but unpaid dividends. The Company is required to redeem the Series I two years following the date that is the later of the (i) final closing of the tranche (as designated in the applicable subscription agreement) or (ii) the expiration date of the tranche that such shares to be redeemed were a part of. The Company was required to redeem such shares of Series I between May 2, 2021 and June 10, 2021, at a price equal to the stated value plus any accrued but unpaid dividends. The issuance of the shares were accounted for under ASC 480-10-25-4, which requires liability treatment for certain mandatorily redeemable financial instruments, and the cumulative dividends are recorded as interest expense. During the nine months ended September 30, 2021, 562 shares of Series I preferred stock were exchanged for 317 shares of Series R preferred stock, and 245 shares of Series W preferred stock. The shares were issued and exchanged within the terms of the agreement and no gain or loss was recognized. As of September 30, 2021, there were 235 shares of Series I preferred stock issued and outstanding which the Company was required to, and failed to redeem between May 2, 2021, and June 10, 2021, for an aggregate redemption price (equal to the stated value) of $235,000. Series J On April 3, 2019, the Company designated 100,000 shares of preferred stock as Series J. The Series J has a stated value of $1,000 per share and holders are entitled to receive dividends on an as-converted basis with the Company’s common stock. The Series J preferred stock is convertible into shares of the Company’s common stock, on the terms and conditions set forth in the Series J COD, which includes certain make-good shares for certain prior investors. During the nine months ended September 30, 2021, the Company issued 1,203,924 shares of common stock upon the conversion of 47.5 shares of Series J preferred stock. For the nine months ended September 30, 2021, the Company recognized a loss on conversion of Series J preferred stock in the amount of $64,889. As of September 30, 2021, there were 225 shares of Series J preferred stock issued and outstanding. Series K On June 3, 2019, the Company designated 4,000 shares of preferred stock as Series K. The Series K has a stated value of $1,000 per share. Series K holders are entitled to cumulative dividends at the annual rate of 8% of the stated value, payable quarterly within 60 days from the end of each fiscal quarter. The Series K is not entitled to any voting rights except as may be required by applicable law, and is not convertible into common stock. The Company has the right to redeem the Series K at any time while the Series K are outstanding at a price equal to the stated value plus any accrued but unpaid dividends. The Company is required to redeem the Series K two years following the date that is the later of the (i) final closing of the tranche (as designated in the applicable subscription agreement) or (ii) the expiration date of the tranche that such shares to be redeemed were a part of. The Company is required to redeem such shares of Series K between August 5, 2021 and April 24, 2022, at a price equal to the stated value plus any accrued but unpaid dividends. The issuance of the shares were accounted for under ASC 480-10-25-4, which requires liability treatment for certain mandatorily redeemable financial instruments, and the cumulative dividends are recorded as interest expense. During the nine months ended September 30, 2021, 2,580 shares of Series K preferred stock were exchanged for 1,822 shares of Series R preferred stock, and 758 shares of Series W preferred stock. The shares were issued and exchanged within the terms of the agreement and no gain or loss was recognized. As of September 30, 2021, there were 581 shares of Series K preferred stock issued and outstanding. Of these 581 shares, the Company was required to, and failed to redeem between August 5, 2021 and August 28, 2021, an aggregate of 120 such shares for an aggregate redemption price (equal to the stated value) of $120,000. Series L On June 3, 2019, the Company designated 100,000 shares of preferred stock as Series L. The Series L has a stated value of $1,000 per share and holders are entitled to receive dividends on an as-converted basis with the Company’s common stock. The Series L preferred stock is convertible into shares of the Company’s common stock, on the terms and conditions set forth in the Series L COD, which includes certain make-good shares for certain prior investors. During the nine months ended September 30, 2021, the Company issued an aggregate of 15,265,754 shares of common stock upon conversion of 472 shares of Series L preferred stock. For the nine months ended September 30, 2021, the Company recognized a loss on conversion of Series L preferred stock in the amount of $740,696. As of September 30, 2021, there were 660 shares of Series L preferred stock issued and outstanding. Series M Pursuant to the Amended and Restated Certificate of Designation of Series M preferred stock filed with the Secretary of State of Nevada on July 1, 2020, the Company designated 800,000 shares of its preferred stock as Series M preferred stock. Each share of Series M preferred stock has a stated value of $25. The Series M preferred stock is not convertible into common stock. The holders of outstanding shares of Series M preferred stock are entitled to receive dividends, at the annual rate of 10%, payable monthly, payable in preference and priority to any payment of any dividend on the common stock. The Series M preferred stock is entitled to a liquidation preference in an amount equal to $25 per share plus any declared but unpaid dividends, before any payments to holders of common stock. The Series M preferred stock have no pre-emptive or subscription rights, and there are no sinking fund provisions applicable to the Series M preferred stock. The Series M preferred stock does not have voting rights, except as required by law and with respect to certain protective provisions set forth in the Certificate of Designation of Series M preferred stock. To the extent it may lawfully do so, the Company may, in its sole discretion, at any time when there are outstanding shares of Series M preferred stock, redeem any or all of the then outstanding shares of Series M preferred stock at a redemption price of $37.50 per share (150% of the stated value) plus any accrued but unpaid dividends. During the year ended December 31, 2020, prior to the terms of the Series M preferred stock being amended, holders of Series M preferred stock converted an aggregate of 320 Series M shares into an aggregate of 137,052 shares of the Company’s common stock. The Company did not recognize a gain or loss since the shares were converted within the terms of the agreement. During the nine months ended September 30, 2021, the Company issued an aggregate of 1,177 shares of Series M preferred stock for an aggregate purchase price of $29,425 and exchanged an aggregate of 3,200 shares of Series M preferred stock for 120 shares of Series R preferred stock and recognized a loss on the exchange in the amount of $40,000. As of September 30, 2021, there were 40,340 shares of Series M preferred stock issued and outstanding. Series O On April 27, 2020, the Company designated 2,000 shares of preferred stock as Series O preferred stock. The Series O preferred stock has a stated value of $1,000 per share, and entitles holders to receive cumulative dividends (i) in cash at an annual rate of 8% of the stated value, and (ii) in shares of common stock of the Company (valued based on the conversion price as in effect on the last trading day of the applicable fiscal quarter) at an annual rate of 4% of the stated value, payable quarterly within 60 days from the end of such fiscal quarter. The Series O preferred stock has a liquidation preference equal to the stated value plus any accrued but unpaid dividends, in preference to the common stock. The Series O preferred stock has no preemptive or subscription rights, and there is no sinking fund provision applicable to the Series O preferred stock. The Series O preferred stock does not have voting rights except as required by law. The Series O preferred stock is convertible into common stock of the Company in an amount determined by dividing 200% of the stated value of the Series O preferred stock being converted by the conversion price, provided that, the Series O may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The conversion price is equal to the average closing sale price of the common stock for the five trading days prior to the conversion date. The Company has the right (but no obligation) to redeem the Series O preferred stock at any time while the Series O preferred stock are outstanding at a redemption price equal to the stated value plus any accrued but unpaid dividends. The cumulative dividends are recorded as interest expense. During the nine months ended September 30, 2021, the Company issued an aggregate of 27,357,198 shares of common stock upon conversion of 1,060 shares of Series O preferred stock and exchanged an aggregate of 120 shares of Series O preferred stock for 120 shares of Series R preferred stock. The shares were issued and exchanged within the terms of the agreement and no gain or loss was recognized. As of September 30, 2021, there were 815 shares of Series O preferred stock issued and outstanding, and during the nine months ended September 30, 2021, the Company issued an aggregate of 495,366 shares of common stock in prorated 4% annualized dividends. Series P On April 27, 2020, the Company designated 500 shares of preferred stock as Series P preferred stock. The Series P preferred stock has a stated value of $1,000 per share, and entitles holders to receive dividends on an as-converted basis with the Company’s common stock. The Series P preferred stock is convertible into shares of the Company’s common stock, on the terms and conditions set forth in the Certificate of Designation of Series P preferred stock, which includes certain make-good shares for certain prior investors, and provided that, the Series P preferred stock may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The Series P preferred stock entitles the holders to a payment on an as-converted and pari passu basis with the common stock upon any liquidation. The Series P preferred stock has no preemptive or subscription rights, and there is no sinking fund or redemption provisions applicable to the Series P preferred stock. The Series P preferred stock votes on an as-converted basis with the common stock, subject to the beneficial ownership limitation. During the nine months ended September 30, 2021, the Company issued an aggregate of 9,720,267 shares of common stock upon conversion of 280 shares of Series P preferred stock. For the nine months ended September 30, 2021, the Company recognized a loss on conversion of Series P preferred stock in the amount of $335,081. As of September 30, 2021, there were 76 shares of Series P preferred stock issued and outstanding. Series Q On August 21, 2020, the Company designated 2,000 shares of preferred stock as Series Q preferred stock. The Series Q preferred stock has a stated value of $1,000 per share, and entitles holders to receive cumulative dividends in cash at an annual rate of 12% of the stated value, payable quarterly within 60 days from the end of such fiscal quarter. The Series Q preferred stock has a liquidation preference equal to the stated value plus any accrued but unpaid dividends, in preference to the common stock. The Series Q preferred stock has no preemptive or subscription rights, and there is no sinking fund provision applicable to the Series Q preferred stock. The Series Q preferred stock does not have voting rights except as required by law. The Series Q preferred stock is convertible into common stock of the Company in an amount determined by dividing 200% of the stated value of the Series Q preferred stock being converted by the conversion price, provided that, the Series Q may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The conversion price is equal to the average closing sale price of the common stock for the five trading days prior to the conversion date. The Company has the right (but no obligation) to redeem the Series Q preferred stock at any time while the Series Q preferred stock are outstanding at a redemption price equal to the stated value plus any accrued but unpaid dividends. The cumulative dividends are recorded as interest expense. During the nine months ended September 30, 2021, the Company issued an aggregate of 10,668,656 shares of common stock upon conversion of 420 shares of Series Q preferred stock, and exchanged 15 shares of Series F preferred stock for 15 shares of Series Q preferred stock. The shares were issued and exchanged within the terms of the agreement and no gain or loss was recognized. As of September 30, 2021, there were 620 shares of Series Q preferred stock issued and outstanding. Series R On November 16, 2020, the Company designated 5,000 shares of preferred stock as Series R preferred stock. The Series R has a stated value of $1,000 per share, and entitles holders to receive cumulative dividends in cash at an annual rate of 10% of the stated value, payable quarterly within 60 days from the end of such fiscal quarter. The Series R holders are not entitled to any voting rights except as may be required by applicable law. The Series R is convertible into common stock of the Company in an amount determined by dividing 200% of the stated value of the Series R being converted by the conversion price; certain prior investors will also be entitled to certain make-good shares; provided that, the Series R may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The conversion price will be equal to the average closing sale price of the common stock for the five trading days prior to the conversion date. The Company will have the right (but no obligation) to redeem the Series R at any time while the Series R are outstanding at a redemption price equal to, if paid in cash, the stated value plus any accrued but unpaid cash dividends, or, if paid in shares of common stock, in an amount of shares determined by dividing the stated value being redeemed by the conversion price. The subscribers were issued warrants to purchase shares of common stock with the purchase of Series R. During the nine months ended September 30, 2021, the Company issued an aggregate of 2,481 shares of Series R preferred stock for an aggregate purchase price of $2,480,750 and exchanged an aggregate of 15 shares of Series G preferred stock, 317 shares of Series I preferred stock, 1,822 shares of Series K preferred stock, 3,200 shares of Series M preferred stock, and 120 shares of Series O preferred stock for an aggregate of 2,394 shares of Series R preferred stock, and issued an aggregate of 33,520,261 shares of common stock upon conversion of 1,085 shares of Series R preferred stock. The shares were issued and exchanged within the terms of the agreement and no gain or loss was recognized. As of September 30, 2021, there were 4,280 shares of Series R preferred stock along with 111,298,340 Series A warrants (with an exercise price of $0.05) and 55,177,670 Series B warrants (with an exercise price of $0.10) issued and outstanding with a fair value of $11,181,822. The warrants were valued using the Black Scholes model (see additional information under warrants footnote). Series S On February 5, 2021, the Company designated 430 shares of preferred stock as Series S. The Series S has a stated value of $1,000 per share, and entitles holders to receive cumulative dividends in cash at an annual rate of 12% of the stated value, payable quarterly within 60 days from the end of such fiscal quarter. The Series S holders are not entitled to any voting rights except as may be required by applicable law. The Series S is convertible into common stock of the Company in an amount determined by dividing 200% of the stated value of the Series S being converted by the conversion price, provided that, the Series S may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The conversion price will be equal to the average closing sale price of the common stock for the five trading days prior to the conversion date. The Company has the right (but no obligation) to redeem the Series S at any time while the Series S are outstanding at a redemption price equal to the stated value plus any accrued but unpaid dividends. During the nine months ended September 30, 2021, the Company issued an aggregate 365 shares of Series S preferred stock in exchange for an aggregate of 365 Series G preferred stock and issued an aggregate of 5,495,406 shares of common stock upon conversion of 195 shares of Series S preferred stock. The shares were issued and exchanged within the terms of the agreement and no gain or loss was recognized. As of September 30, 2021, there were 170 shares of Series S preferred stock issued and outstanding. Series T On February 24, 2021, the Company designated 630 shares of preferred stock as Series T. The Series T has a stated value of $1,000 per share, and entitles holders to receive cumulative dividends in cash at an annual rate of 10% of the stated value, payable monthly. The Series T holders are not entitled to any voting rights except as may be required by applicable law. The Series T is convertible into common stock of the Company pursuant to the Series T COD, provided that, the Series T may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The Company will have the right (but no obligation) to redeem the Series T at any time while the Series T are outstanding at a redemption price equal to the stated value plus any accrued but unpaid dividends. On March 1, 2021, the Company issued an aggregate of 630 shares of Series T Preferred Stock to an accredited investor (the “Purchaser’’) per terms of a Securities Purchase Agreement (the “SPA”). Per the SPA, the Company agreed to sell to Purchaser, and Purchaser agreed to purchase from the Company, 630 shares of the Company’s Series T, and two-year cashless warrants to acquire 25,200,000 shares of the Company’s common stock, valued at $0.05 per share per terms of the SPA, which may be exercised at any time in whole or in part. Per the SPA, the Series T, including any convertible shares acquired pursuant to exercise of the warrants, the Company shall pay 10% annual dividends in cash, paid monthly. Purchaser may convert any portion of the Series T, including convertible shares acquired pursuant to exercise of the warrants, at any time into shares of the Company’s common stock at an agreed upon conversion rate per terms of the SPA. The purchaser and the Company agreed that in lieu of the purchase price for the Series T, the Purchaser transferred to the Company real property, with an aggregate value agreed to be $630,000 based on an appraisal from an international independent company. The real property consists of residential real estate in Buenos Aires Argentina valued at $580,000, and eight undeveloped lots valued at $50,000 in Terralta private neighborhood development. The real property exchanged for 630 shares of Series T was recorded at $630,000 and reflected on the balance sheet as a long term asset for sale. The fair value of the warrants associated with acquiring 25,200,000 preferred shares were valued at $2,037,849, using the Black Scholes model and accounted for as deemed dividends and reflected in stockholder’s equity as accumulated paid in capital. The Company has actively listed the residential real property for sale and on September 13, 2021, received an offer for the property for $464,000, which is $116,000 below the original independent appraisal of $580,000. The offer was accepted and the Company is currently completing all formalities required to close the transaction. Based on the above indicator of impairment, during the quarter ended September 30, 2021, the Company adjusted the original value of the long term asset for sale from $630,000 to $514,000 on the balance sheet and recorded an impairment of $116,000 in the consolidated statement of operations. Series U On May 26, 2021, the Company designated 5,000 shares of preferred stock as Series U. The Series U has a stated value of $1,000 per share. The Series U holders are not entitled to any dividends and do not have any voting rights except as may be required by applicable law. The Series U is convertible into common stock of the Company in an amount determined by dividing 150% of the stated value of the Series U being converted by the conversion price; certain prior investors will also be entitled to certain make-good shares; provided that, the Series U may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The conversion price will be equal to the lesser of $0.20 or the average closing sale price of the common stock for the five trading days prior to the conversion date. The Company has the right (but no obligation) to redeem the Series U at any time at a redemption price equal to, if paid in cash, the stated value, or, if paid in shares of common stock, in an amount of shares determined by dividing 200% of the stated value being redeemed by the conversion price then in effect, and adding any applicable make-good shares. During the nine months ended September 30, 2021, the Company issued 965 shares of Series U at a stated value of $965,000. During the nine months ended September 30, 2021, the Company issued an aggregate of 8,729,034 shares of common stock upon conversion of 330 shares of Series U preferred stock. The shares were issued within the terms of the agreement and no gain or loss was recognized. As of September 30, 2021, there were 635 shares of Series U preferred stock issued and outstanding. Series V On September 16, 2021, the Company filed a certificate of withdrawal of the Company’s certificate of designation of Series V preferred stock, and filed a certificate of designation for a new series of Series V preferred stock with the Secretary of State of Nevada. Pursuant to the Series V COD, the Company designated 3,000 shares of preferred stock as Series V. The Series V has a stated value of $100,000 per share, and will be entitled to an annual distribution of 25% of annual net profits of newly established Company wholly-owned, Water On Demand subsidiaries, designated by each Holder, paid within 3 months of subsidiary’s accounting year-end. The Series V will not be entitled to any voting rights except as may be required by applicable law. The Series V will be convertible into common stock of the Company pursuant to the Series V COD, provided that, the Series V may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The Company will have the right (but no obligation) to redeem the Series V at any time at a redemption price equal to, if paid in cash, the stated value plus any accrued but unpaid distributions of 25% of subsidiary’s annual net profits. Series W On April 28, 2021, the Company designated 3,390 shares of preferred stock as Series W. The Series W has a stated value of $1,000 per share, and Series W holders are entitled to cumulative dividends in cash at an annual rate of 12% of the stated value, payable quarterly. The Series W is not entitled to any voting rights except as may be required by applicable law. The Series W is convertible into common stock of the Company in an amount determined by dividing 200% of the stated value of the Series W being converted by the conversion price; provided that, the Series W may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock. The conversion price will be equal to the average closing sale price of the common stock for the five trading days prior to the conversion date. The Company has the right (but

Restricted Stock and Warrants

Restricted Stock and Warrants	9 Months Ended
	Sep. 30, 2021
Share-based Payment Arrangement [Abstract]
RESTRICTED STOCK AND WARRANTS	4. RESTRICTED STOCK AND WARRANTS Restricted Stock to CEO Between May 12, 2016, and March 1, 2021, the Company entered into Restricted Stock Grant Agreements (“the RSGAs”) with its Chief Executive Officer, Riggs Eckelberry, to create management incentives to improve the economic performance of the Company and to increase its value and stock price. All shares issuable under the RSGAs are performance based shares. The RSGAs provides for the issuance of up to an aggregate of 202,109,214 shares of the Company’s common stock to Mr. Eckelberry provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period as reported in the Company’s quarterly or annual financial statements, the Company will issue up to an aggregate of 101,054,607 shares of its common stock; b) If the Company’s consolidated operating profit ( Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization Restricted Stock to Employees, Board and Consultants Between May 12, 2016, and September 14, 2021, the Company entered into Restricted Stock Grant Agreements (“the E, B &C RSGAs”) with its employees, the Board and consultants, to create management incentives to improve the economic performance of the Company and to increase its value and stock price. All shares issuable under the E, B &C RSGAs are performance based shares. The E, B &C RSGAs provide for the issuance of up to 218,141,685 shares of the Company’s common stock to employees, Board and consultants provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period as reported in the Company’s quarterly or annual financial statements, the Company will issue up to an aggregate of 109,070,842 shares of its common stock; b) If the Company’s consolidated operating profit Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), On August 14, 2019, the Board of Directors approved an amendment to the RSGAs and E&C RSGAs to include an alternative vesting schedule for the Grantees. The Grantees can elect to participate in the alternate vesting schedule for grants received at least two years prior to the date requested. On the first day of each calendar month, an aggregate dollar amount of restricted stock equal to an aggregate of 5% of the total dollar amount of the Company’s common stock that traded during the prior calendar month, will vest, divided equally among all RSGAs and E&C RSGAs that have duly elected to participate in the alternate vesting schedule, with value based on the fair market value under the respective RSGAs and E&C RSGAs. The fair market value shall equal the average of the trailing ten (10) closing trade prices of the Company’s common stock on the last ten (10) trading days of the month immediately prior to the date of determination as quoted on the public securities trading market on which the Company’s common stock is then traded. If the fair market value of the Company’s common stock on the date the shares are vested is less than the fair market value of the Company’s common stock on the effective date of the RSGA or E&C RSGA, then the number of vested shares issuable (assuming all conditions are satisfied) shall be increased so that the aggregate fair market value of vested shares issuable on the vesting date equals the aggregate fair market value that such number of shares would have had on the effective date. Upon the occurrence of a Company performance goal, the right to participate in the alternate vesting schedule will terminate, and the vesting of the remaining unvested shares will be as set forth under the restricted stock award agreement. During the nine months ended September 30, 2021, per electing and qualifying for the Restricted Stock Grant Agreement alternate vesting schedule, the Company issued to Mr. T. Riggs Eckelberry, one employee and one consultant an aggregate of 2,771,892 common shares of the Company’s common stock with a value of $211,520, calculated using the closing share prices on the dates of the vesting agreements. Warrants During the nine months ended September 30, 2021, the Company issued warrants to purchase 200,678,283 shares of common stock, associated with sales of preferred stocks and realized $50,000 from exercise of 1,000,000 warrants at an exercise price of $0.05. A summary of the Company’s warrant activity and related information follows for the nine months ended September 30, 2021. 2021 Weighted average Number of exercise Warrants price Outstanding - beginning of period 15,922,044 $ 4.24 Granted 200,678,283 $ 0.07 Exercised (1,000,000 ) $ 0.05 Forfeited (122,044 ) $ (4.17 ) Outstanding - end of period 215,478,283 $ 0.07 At September 30, 2021 the weighted average remaining contractual life of warrants outstanding was as follows: 2021 Weighted Remaining Exercise Warrants Warrants Contractual Prices Outstanding Exercisable Life (years) $ 0.05 136,498,340 136,498,340 0.13 - 99 $ 0.02 600,000 600,000 4.92 $ 0.10 64,827,670 64,827,670 0.13 - 0.99 $ 0.25 3,860,000 3,860,000 1.75 - 1.99 $ 0.0275 8,727,273 8,727,273 9.66 $ 1.00 965,000 965,000 2.75 - 2.99 215,478,283 215,478,283 During the period ended September 30, 2021, the Company issued 9,327,273 common stock purchase warrants for services, and recognized stock compensation expense of $62,480. At September 30, 2021, the aggregate intrinsic value of the warrants outstanding was $269,197.

Convertible Promissory Notes

Convertible Promissory Notes	9 Months Ended
	Sep. 30, 2021
Debt Disclosure [Abstract]
CONVERTIBLE PROMISSORY NOTES	5. CONVERTIBLE PROMISSORY NOTES As of September 30, 2021, the outstanding convertible promissory notes are summarized as follows: Convertible Promissory Notes, net of discount $ 3,061,761 Less current portion 2,999,486 Total long-term liabilities $ 62,275 Maturities of long-term debt for the next two years are as follows: Period Ended September Amount 2022 $ 3,019,780 2023 62,275 $ 3,082,055 At September 30, 2021, the Company had $3,082,055 in convertible promissory notes and has a remaining debt discount of $20,294, leaving a net balance of $3,061,761. On various dates from 2014 through May 2015, the Company issued unsecured convertible promissory notes (the “2014-2015 Notes”), that matured on various dates and were extended sixty (60) months from the effective date of each Note. The 2014-2015 Notes bear interest at 10% per year. The 2014-2015 Notes may be converted into shares of the Company’s common stock at conversion prices ranging from the lesser of $4,200 to $9,800 (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or 50% of the lowest trade price on any trade day following issuance of the 2014-2015 Notes. In addition, for as long as the 2014-2015 Notes or other convertible notes in effect between the purchaser and the Company are outstanding, if the Company issues any security with terms more favorable than the terms of the 2014-2015 Notes or such other convertible notes or a term was not similarly provided to the purchaser of the 2014-2015 Notes or such other convertible notes, then such more favorable or additional term shall, at the purchaser’s option, become part of the 2014-2015 Notes and such other convertible notes. The conversion feature of the 2014-2015 Notes was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the 2014-2015 Notes. During the nine months ended September 30, 2021, the Company issued 13,927,621 shares of common stock, upon conversion of $81,150 in principal, plus accrued interest of $52,555. As of September 30, 2021, the 2014-2015 Notes had an aggregate remaining balance of $930,000, which is short term. The unsecured convertible promissory notes (the “OID Notes”) had an aggregate remaining balance of $184,124, plus accrued interest of $13,334. The OID Notes included an original issue discount and one-time interest, which has been fully amortized. The OID Notes matured on December 31, 2017, which were extended to September 30, 2018. The OID Notes were convertible into shares of the Company’s common stock at a conversion price initially of $30,620. After the amendment, the conversion price changed to the lesser of $5,600 per share, or b) fifty percent (50%) of the lowest trade price of common stock recorded since the original effective date of this note, or c) the lowest effective price per share granted to any person or entity after the effective date. The conversion feature of the notes was considered a derivative in accordance with current accounting guidelines, because of the reset conversion features of the notes. As of September 30, 2021, the remaining balance was $62,275, which is long term. The Company issued various unsecured convertible promissory notes (the “2015-2016 Notes”), on various dates ending on May 19, 2016. The 2015-2016 Notes matured and were extended from the date of each tranche through maturity dates ending on May 19, 2020. The 2015-2016 Notes bear interest at 10% per year. The 2015-2016 Notes may be converted into shares of the Company’s common stock at conversion prices ranging from the lesser of $1,400 to $5,600 (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or 50% of the lowest trade price on any trade day following issuance of the 2015-2016 Notes. The conversion feature of the 2015-2016 Notes was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the 2015-2016 Notes. As of September 30, 2021, the remaining balance of the 2015-2016 Notes was $1,200,000, which is short term. The Company issued a convertible note (the “Dec 2015 Note”) in exchange for accounts payable in the amount of $432,048, which could be converted into shares of the Company’s common stock after December 31, 2015. The Dec 2015 Note was accounted for under ASC 470, whereby, a beneficial conversion feature was recorded at time of issuance. The Dec 2015 Note did not meet the criteria of a derivative, and was accounted for as a beneficial conversion feature, which was amortized over the life of the Dec 2015 Note and recognized as interest expense in the financial statements. On January 1, 2016, the Dec 2015 Note met the criteria of a derivative and was accounted for under ASC 815. The Dec 2015 Note has zero stated interest rate, and the conversion price shall be equal to 75% of the average three lowest last sale prices traded during the 25 trading days immediately prior to conversion. As of September 30, 2021, the remaining balance on the Dec 2015 Note was $167,048, which is short term. The Company issued a convertible note (the “Sep 2016 Note”) in exchange for accounts payable in the amount of $430,896, which could be converted into shares of the Company’s common stock after September 15, 2016. The Sep 2016 Note was accounted for under ASC 470, whereby, a beneficial conversion feature was recorded at time of issuance. The Sep 2016 Note met the criteria of a derivative and was accounted for under ASC 815. The Sep 2016 Note has zero stated interest rate, and the conversion price shall be equal to 75% of the average three lowest last sale prices traded during the 25 trading days immediately prior to conversion. The Sep 2016 Note did not meet the criteria of a derivative at the date of the issuance, and was accounted for as a beneficial conversion feature, which was amortized over the life of the Sep 2016 Note and recognized as interest expense in the financial statements. The conversion feature of the Sep 2016 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion feature of the Sep 2016 Note. As of September 30, 2021, the remaining balance on the Sep 2016 Note was $430,896, which is short term. The Company issued two (2) unsecured convertible promissory notes (the “Apr & May 2018 Notes”), in the aggregate amount of $300,000 on April 2, 2018 and May 31, 2018. The Apr & May 2018 Notes had maturity dates of April 2, 2019 and May 31, 2019, respectively. The Apr & May 2018 Notes bear interest at 10% per year. The Apr & May 2018 Notes may be converted into shares of the Company’s common stock at a variable conversion price of 50% of the lesser of the lowest trading price twenty-five (25) trading days prior to conversion. The conversion feature of the Apr & May 2018 Notes was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Notes. During the nine months ended September 30, 2019, the Company issued 12,500 shares of common stock upon conversion of principal in the amount of $6,523, plus accrued interest of $4,727, with a fair value loss on conversion of $16,250. On March 13, 2019, the Company entered into a settlement agreement with the investor in the amount of $570,000, based on the outstanding balance due and payable under the Apr & May 2018 Notes. The Company set up a reserve of 2,630,769 shares of common stock of the Company for issuance upon conversion by the investor of the amounts owed under the Notes, in accordance with the terms of the Notes, including, but not limited to the beneficial ownership limitations contained in the Notes. In addition to the foregoing, upon the sale by the investor of the settlement shares as delivered to the investor by the Company, resulting in total net proceeds less than the settlement value, the investor is entitled to additional settlement shares of the Company’s common stock. If after the investor has sold all settlement shares, the investor delivers a written notice to the Company certifying that the investor is entitled to additional settlement shares of the Company’s common stock (the “Make-Whole Shares”). The number of make-whole shares being equal to the greater of ((i) zero and (ii) the quotient of (1) the difference of (x) the settlement value with respect to each sale of shares by the Investor after the delivery of the Settlement Shares, minus (y) the aggregate net consideration received by the Investor from the resale of all shares of common stock issued by the Company, divided by (2) the average trailing closing price for ten (10) trading days for the shares immediately preceding the date of delivery of the make-whole shares. As of September 30, 2021, the remaining balance on the May 2018 Note was $218,064, which is short term. The Company entered into an unsecured convertible promissory note (the “Nov 20 Note”), on November 19, 2020 in the amount of $50,000. The Company received funds in the amount of $50,000. The Nov 20 Note matures on November 19, 2021, twelve months from the effective date of the Note. The Note may be extended sixty (60) months from the maturity date. The Nov 20 Note bears interest at 10% per year. The Nov 20 Note may be converted into shares of the Company’s common stock at a lesser price of $0.05 per share or (b) fifty percent (50%) of the lowest trade price of common stock recorded on any trade after the effective date, or (c) the lowest effective price per share granted. In addition, for each conversion, in event that shares are not delivered by the fourth business day (inclusive of the day of conversion), a penalty of $2,000 per day shall be assessed for each day after the third business day until the shares are delivered. The conversion feature of the Nov 20 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Note. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $10,047 during the nine months ended September 30, 2021. During the nine months ended September 30, 2021, the Company paid off $15,228 in cash, of the Nov 20 Note. As of September 30, 2021, the remaining balance of the Nov 20 Note was $13,772, which is short term. The Company entered into an unsecured convertible promissory note (the “Jan 21 Note”), on January 25, 2021 in the amount of $60,000. The Company received funds in the amount of $60,000. The Jan 21 Note matures on January 25, 2022, twelve months from the effective date of the Note. The Note may be extended sixty (60) months from the maturity date. The Jan 21 Note bears interest at 10% per year. The Jan 21 Note may be converted into shares of the Company’s common stock at a conversion price equal to the lower of (a) $0.05 per share, (b) fifty percent (50%) of the lowest trade price of common stock recorded on any trade after the effective date, or (c) the lowest effective price per share granted. In addition, for each conversion, in event that shares are not delivered by the fourth business day (inclusive of the day of conversion), a penalty of $2,000 per day shall be assessed for each day after the third business day until the shares are delivered. The conversion feature of the Jan 25 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Note. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $23,358 during the nine months ended September 30, 2021. As of September 30, 2021, the balance of the Jan 21 Note was $60,000, which is short term. We evaluated the financing transactions in accordance with ASC Topic 815, Derivatives and Hedging, and determined that the conversion feature of the convertible promissory notes was not afforded the exemption for conventional convertible instruments due to its variable conversion rate. The note has no explicit limit on the number of shares issuable, so they did not meet the conditions set forth in current accounting standards for equity classification. The Company elected to recognize the note under paragraph 815-15-25-4, whereby, there would be a separation into a host contract and derivative instrument. The Company elected to initially and subsequently measure the note in its entirety at fair value, with changes in fair value recognized in earnings. The Company recorded a derivative liability representing the imputed interest associated with the embedded derivative. The derivative liability is adjusted periodically according to the stock price fluctuations. The derivative liability recognized in the financial statements as of September 30, 2021 was $16,511,716.

Revenue from Contracts with Cus

Revenue from Contracts with Customers	9 Months Ended
	Sep. 30, 2021
Revenue From Contracts With Customers [Abstract]
REVENUE FROM CONTRACTS WITH CUSTOMERS	6. REVENUE FROM CONTRACTS WITH CUSTOMERS Equipment Contracts Revenues and related costs on equipment contracts are recognized as the performance obligations for work are satisfied over time in accordance with Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers. Under ASC 606, revenue and associated profit will be recognized as the customer obtains control of the goods and services promised in the contract (i.e., performance obligations). All un-allocable indirect costs and corporate general and administrative costs are charged to the periods as incurred. However, in the event a loss on a contract is foreseen, the Company will recognize the loss as it is determined. The following table represents a disaggregation of revenue by type of good or service from contracts with customers for the nine months ended September 30, 2021 and 2020. Nine months Ended September 30, 2021 2020 Equipment Contracts $ 1,903,190 $ 1,879,727 Component Sales 841,203 1,076,574 Services Sales 82,634 108,457 Rental Income 21,260 - $ 2,848,287 $ 3,064,758 Revenue recognition for other sales arrangements, such as sales for components, service and licensing fees will remain materially consistent. Contract assets represents revenues recognized in excess of amounts billed on contracts in progress. Contract liabilities represents billings in excess of revenues recognized on contracts in progress. Assets and liabilities related to long-term contracts are included in current assets and current liabilities in the accompanying balance sheets, as they will be liquidated in the normal course of the contract completion. The contract asset for the nine months ended September 30, 2021 and for the year ended December 31, 2020, was $71,861 and $148,734, respectively. The contract liability for the nine months ended September 30, 2021 and for the year ended December 31, 2020, was $538,706 and $340,551, respectively.

Financial Assets

Financial Assets	9 Months Ended
	Sep. 30, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
FINANCIAL ASSETS	7. FINANCIAL ASSETS Convertible Note Receivable The Company purchased a 10% convertible note in the amount of $80,000, through a private placement with Water Technologies International, Inc (“WTII”). The Note is convertible into common stock of WTII at a price of 65% of the lowest trading price for the ten (10) trading days immediately prior to the conversion date. The conversion price shall not be lower than a price of $0.0001 per share. As of September 30, 2021, the note included principal of $80,000 plus accrued interest of $53,879 for a total of $133,879. The Note was considered impaired as of December 31, 2020, and an allowance was recognized in the financials in the amount of $133,879, during the year ended December 31, 2020, due to impairment. Fair value investment in Securities On May 15, 2018, the Company received 4,000 shares of WTII Series C convertible preferred stock for the use of OriginClear, Inc. technology associated with their proprietary electro water separation system. Each share of Series C convertible preferred stock is convertible into 1,000 shares of WTII common stock. The stock was valued at fair market value of $0.0075 for a price of $30,000 on the date of issuance. The Company analyzed the licensing agreement using ASU 606 to determine the timing of revenue recognition. The licensing of the intellectual property (IP) is distinct from the non-license goods or services and has significant standalone functionality that provides a benefit or value. The functionality will not change during the license period due to the licensor’s activities. Because the significant standalone functionality was delivered immediately, the revenue was recognized in the financial statements as of September 30, 2018. As of September 30, 2021, the fair value of the preferred shares was $40,000, based upon the change in market price.

Loans Payable

Loans Payable	9 Months Ended
	Sep. 30, 2021
Loans Payable Disclosure [Abstract]
LOANS PAYABLE	8. LOANS PAYABLE Secured Loans Payable The Company entered into short term loans with various lenders for capital expansion secured by the Company’s assets in the amount of $1,749,970, which included finance cost of $624,810. The term of the loans ranged from two months to six months. The finance cost was amortized over the terms of the loans, which had various maturity dates ranging from October 2018 through February 2019. As of December 31, 2019, the finance cost was fully amortized. During the period ended September 30, 2021, the Company settled the majority of the loans in the amount of $262,250, of which $157,250 was recognized on the statement of operations as a gain on write-off of loan payable. The net balance as of September 30, 2021 and December 31, 2020 was $80,646 and $342,896, respectively. Loan Payable-Related Party The Company’s CEO loaned the Company $248,870 as of September 28, 2018. The loans bear interest at various rates to be repaid over a period of three (3) years at various maturity dates. The funds were used for operating expenses. During the period ended September 30, 2021, the CEO loaned the Company $48,116, and the Company made principal payments in the amount of $142,999, and recorded interest of $3,651, leaving a balance of $0 as of September 30, 2021. Small Business Administration Loans Between April 30, 2020 and September 12, 2020, the Company received total loan proceeds in the amount of $505,000, which included an aggregate of $345,000 under the Paycheck Protection Program (the “PPP”) under the Coronavirus Aid, Relief and Economic Security Act, an Economic Injury Disaster Loan in the amount of $150,000 and an Economic Injury Disaster Grant in the amount of $10,000. The principal and accrued interest under the PPP is forgivable if the Company uses the PPP loan proceeds for eligible purposes, including payroll, benefits, rent and utilities, and otherwise complies with PPP requirements. In order to obtain forgiveness of the PPP loan, the Company must submit a request and provide satisfactory documentation regarding its compliance with applicable requirements. The Company must repay any unforgiven principal amount, with interest, on a monthly basis following the deferral period. The Company used the full proceeds of the PPP loan specifically for eligible purposes per requirements of the PPP. For the period ended September 30, 2021, the aggregate amount of $345,000 received under the PPP, and the Economic Injury Disaster Grant in the amount of $10,000 was recognized in the statement of operations as other income due to forgiveness.

Capital Leases

Capital Leases	9 Months Ended
	Sep. 30, 2021
Capital Leases [Abstract]
CAPITAL LEASES	9. CAPITAL LEASES The Company entered into a capital lease for the purchase of equipment during the year ended December 31, 2018. The lease is for a sixty (60) month term, with monthly payments of $757 per month, and a purchase option at the end of the lease for $1.00. As of September 30, 2021, the maturities are summarized as follows: Capital lease $ 10,257 Less current portion 9,088 Total long-term liabilities $ 1,169

Foreign Subsidiary

Foreign Subsidiary	9 Months Ended
	Sep. 30, 2021
Foreign Subsidiary [Abstract]
FOREIGN SUBSIDIARY	10. FOREIGN SUBSIDIARY On January 22, 2020 the Company entered into a strategic partnership with Permionics Separations Solutions, Inc., a unit of India’s Permionics Group (“Permionics”) for the Asia-Pacific Region. This strategic partnership assists the Company with overcoming the typical hurdles in commercializing a technology overseas with engineering support, developing customer proposals, infrastructure to handle logistics and purchasing, inventory and shipping from and into foreign countries, customer training, startup assistance and service. The Company believes that Permionics is best suited to accomplish all of the above for its customers in the Asia-Pacific countries and as a result, has terminated all activities of its fully owned subsidiary, OriginClear Technologies Limited, in Hong Kong, China, working instead with Permionics when applicable.

Assets Held For Sale

Assets Held For Sale	9 Months Ended
	Sep. 30, 2021
Property, Plant and Equipment Assets Held-for-sale Disclosure [Abstract]
ASSETS HELD FOR SALE	11. ASSETS HELD FOR SALE During the nine months ended September 30, 2021, the Company acquired real estate assets to be held for sale to finance their water projects, by issuing 630 shares of preferred stock for a fair value of $630,000, in conjunction with common stock purchase warrants, through an asset purchase agreement. The assets held for sale consisted of residential property, plus eight (8) lots of undeveloped land. The real property has been listed actively on the market to be sold. On September 13, 2021, the Company received an offer for the residential property in the amount of $464,000 from a buyer, and an offer of $50,000 for the eight (8) lots of undeveloped land from an investor for a total of $514,000. The offers were accepted, and the Company is currently completing all formalities required to close the transactions (refer note 3 - Series T). At September 30, 2021, the Company adjusted the fair value and recognized a loss on impairment of the residential property in the amount of $116,000.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2021
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	12. COMMITMENTS AND CONTINGENCIES Facility Rental – Related Party The Company rents from its subsidiary on a month-to-month basis a 12,000 square foot facility in McKinney, Texas at a base rent of $7,000 per month. Warranty Reserve Generally, a PWT project is guaranteed against defects in material and workmanship for one year from the date of completion, while certain areas of construction and materials may have guarantees extending beyond one year. The Company has various insurance policies relating to the guarantee of completed work, which in the opinion of management will adequately cover any potential claims. A warranty reserve has been provided under PWT based on the opinion of management and based on Company history in the amount of $20,000 for the nine months ended September 30, 2021. Litigation On July 26, 2021, Progressive Water Treatment, Inc., OriginClear, Inc., T. Riggs Eckelberry, individually, and Marc Stevens, individually (collectively, the “ Expansion Plaintiffs Expansion On August 10, 2021, Progressive Water Treatment, Inc., OriginClear, Inc., and T. Riggs Eckelberry, individually (collectively, the “ Yellowstone Plaintiffs Yellowstone For the period ended September 30, 2021, there are no material updates to the settlement of the dispute between OriginClear, Inc., and its developmental subsidiary, WaterChain, Inc., and RDI Financial, LLC, an alleged assignee of Interdependence, Inc., as disclosed in greater detail in the Form 10-Q for the period ended March 31, 2021, filed by OriginClear on August 4, 2021. All parties are fully and timely performing under the settlement agreement, and no further issues or proceedings, or fees and costs, are anticipated. For the period ended September 30, 2021, there are no material updates to the ongoing litigation between OriginClear, Inc., Progressive Water Treatment, Inc., and T. Riggs Eckelberry, individually, and GTR Source LLC, as disclosed in greater detail in the Form 10-Q for the period ended March 31, 2021, filed by OriginClear on August 4, 2021. For the period ended September 30, 2021, there are no material updates to the settlement of the dispute between OriginClear, Inc., Progressive Water Treatment, Inc., and T. Riggs Eckelberry, individually, and C6 Capital LLC, as disclosed in greater detail in the Form 10-Q for the period ended March 31, 2021, filed by OriginClear on August 4, 2021. For the period ended September 30, 2021, there are no material updates to the ongoing litigation between OriginClear, Inc. and Auctus Fund, LLC, as disclosed in greater detail in the Form 10-Q for the period ended March 31, 2021, filed by OriginClear on August 4, 2021.

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2021
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	13. SUBSEQUENT EVENTS Management has evaluated subsequent events according to the requirements of ASC TOPIC 855 and has determined that there are the following subsequent events: Between October 1, 2021 and November 5, 2021, the Company entered into subscription agreements with certain accredited investors pursuant to which the Company sold an aggregate of 255 shares of the Company’s Series U preferred stock for an aggregate purchase price of $255,000. The Company also issued an aggregate of 2,550,000 Series A warrants (with an exercise price of $0.10), 1,020,000 Series B warrants (with an exercise price of $0.25), and 255,000 Series C warrants (with an exercise price of $1.00) to the investors. Between November 1, 2021 and November 9, 2021, the Company entered into subscription agreements with certain accredited investors pursuant to which the Company sold an aggregate of 1.5 shares of the Company’s Series V preferred stock for an aggregate purchase price of $150,000. The Company also issued an aggregate of 1,200,000 warrants to the investors. On November 2, 2021, holders of the Company’s Series J Preferred Stock converted an aggregate of 20 Series J shares into an aggregate of 752,482 shares, including make-good shares, of the Company’s common stock. Between October 4, 2021 and November 2, 2021, holders of the Company’s Series L Preferred Stock converted an aggregate of 50 Series L shares into an aggregate of 3,358,649, including make-good shares, of the Company’s common stock. Between October 4, 2021 and November 2, 2021, holders of the Company’s Series O Preferred Stock converted an aggregate of 200 Series O shares into an aggregate of 9,511,600 shares of the Company’s common stock. On November 2, 2021, holders of the Company’s Series P Preferred Stock converted an aggregate of 19 Series P shares into an aggregate of 471,344 shares of the Company’s common stock. Between October 4, 2021 and November 2, holders of the Company’s Series Q Preferred Stock converted an aggregate of 105 Series Q shares into an aggregate of 4,395,512 shares of the Company’s common stock. Between October 4, 2021 and November 2, 2021, holders of the Company’s Series R Preferred Stock converted an aggregate of 848 Series R shares into an aggregate of 45,592,189 shares, including make-good shares, of the Company’s common stock. Between October 4, 2021 and November 2, 2021, holders of Series U Preferred Stock converted an aggregate of 165 Series U shares into an aggregate of 6,901,698 shares of the Company’s common stock. On November 2, 2021, holders of Series W Preferred Stock converted an aggregate of 13 Series W shares into an aggregate of 517,668 shares of the Company’s common stock. Between October 11, 2021 and November 15, 2021, the Company issued to consultants an aggregate of 2,312,237 shares of the Company’s common stock for services including an aggregate of 470,719 shares of common stock for settlement of prior consulting agreement.

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	9 Months Ended
	Sep. 30, 2021
Accounting Policies [Abstract]
Principles of Consolidation	Principles of Consolidation The accompanying consolidated financial statements include the accounts of OriginClear, Inc. and its wholly owned operating subsidiaries, Progressive Water Treatment, Inc., and OriginClear Technologies, Ltd. All material intercompany transactions have been eliminated upon consolidation of these entities.
Cash and Cash Equivalent	Cash and Cash Equivalent The Company considers all highly liquid investments with an original maturity of six months or less to be cash equivalents.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include estimates used to review the Company’s impairments and estimations of long-lived assets, revenue recognition on percentage of completion type contracts, allowances for uncollectible accounts, warranty reserves, inventory valuation, derivative liabilities and other conversion features, fair value investments, valuations of non-cash capital stock issuances and the valuation allowance on deferred tax assets. The Company bases its estimates on historical experience and on various other assumptions that the Company believes to be reasonable in the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.
Net Earnings (Loss) per Share Calculations	Net Earnings (Loss) per Share Calculations Basic loss per share calculations are computed by dividing income (loss) available to common shareholders by the weighted-average number of common shares available. Diluted earnings per share is computed similar to basic earnings per share except that the denominator is increased to include securities or other contracts to issue common stock that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. The Company’s diluted loss per share is the same as the basic loss per share for the nine months ended September 30, 2021, as the inclusion of any potential shares would have had an anti-dilutive effect due to the Company generating a loss. For the Nine months Ended 2021 2020 (Loss) Income to common shareholders (Numerator) $ (12,401,812 ) $ 20,344,331 Basic weighted average number of common shares outstanding (Denominator) 147,762,596 11,598,453 Diluted weighted average number of common shares outstanding (Denominator) 147,762,596 139,029,918 The Company excludes issuable shares from warrants, convertible notes and preferred stock, if their impact on the loss per share is anti-dilutive and includes the issuable shares if their impact is dilutive. September 30, 2021 Anti-dilutive Dilutive Warrant shares 215,478,283 Convertible debt shares 11,460,000 381,025,971 Preferred shares 33,037,213 - September 30, 2020 Warrant shares 122,044 - Convertible debt shares 17,954,000 262,076,475 Preferred shares 34,037,213 -
Revenue Recognition	Revenue Recognition We recognize revenue when services are performed, and at the time of shipment of products, provided that evidence of an arrangement exists, title and risk of loss have passed to the customer, fees are fixed or determinable, and collection of the related receivable is reasonably assured. Revenues and related costs on construction contracts are recognized as the performance obligations for work are satisfied over time in accordance with Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers. Under ASC 606, revenue and associated profit, will be recognized as the customer obtains control of the goods and services promised in the contract (i.e., performance obligations). All un-allocable indirect costs and corporate general and administrative costs are charged to the periods as incurred. However, in the event a loss on a contract is foreseen, the Company will recognize the loss as it is determined. Revisions in cost and profit estimates during the course of the contract are reflected in the accounting period in which the facts for the revisions become known. Provisions for estimated losses on uncompleted contracts are made in the period in which such losses are determined. Changes in job performance, job conditions, and estimated profitability, including those arising from contract penalty provisions, and final contract settlements, may result in revisions to costs and income, which are recognized in the period the revisions are determined. Contract receivables are recorded on contracts for amounts currently due based upon progress billings, as well as retention, which are collectible upon completion of the contracts. Accounts payable to material suppliers and subcontractors are recorded for amounts currently due based upon work completed or materials received, as are retention due subcontractors, which are payable upon completion of the contract. General and administrative expenses are charged to operations as incurred and are not allocated to contract costs.
Contract Receivable	Contract Receivable The Company bills its customers in accordance with contractual agreements. The agreements generally require billing to be on a progressive basis as work is completed. Credit is extended based on evaluation of clients financial condition and collateral is not required. The Company maintains an allowance for doubtful accounts for estimated losses that may arise if any customer is unable to make required payments. Management performs a quantitative and qualitative review of the receivables past due from customers on a monthly basis. The Company records an allowance against uncollectible items for each customer after all reasonable means of collection have been exhausted, and the potential for recovery is considered remote. There was no allowance for doubtful accounts as of September 30, 2021 and December 31, 2020, respectively. The net contract receivable balance was $712,006 and $438,430 at September 30, 2021 and December 31, 2020, respectively.
Indefinite Lived Intangibles and Goodwill Assets	Indefinite Lived Intangibles and Goodwill Assets The Company accounts for business combinations under the acquisition method of accounting in accordance with ASC 805, “Business Combinations,” where the total purchase price is allocated to the tangible and identified intangible assets acquired and liabilities assumed based on their estimated fair values. The purchase price is allocated using the information currently available, and may be adjusted, up to one year from acquisition date, after obtaining more information regarding, among other things, asset valuations, liabilities assumed and revisions to preliminary estimates. The purchase price in excess of the fair value of the tangible and identified intangible assets acquired less liabilities assumed is recognized as goodwill. The Company tests for indefinite lived intangibles and goodwill impairment in the fourth quarter of each year and whenever events or circumstances indicate that the carrying amount of the asset exceeds its fair value and may not be recoverable. In accordance with its policies, the Company performed a qualitative assessment of indefinite lived intangibles at September 30, 2021 and December 31, 2020, and determined there was no impairment of indefinite lived intangibles and goodwill.
Research and Development	Research and Development Research and development costs are expensed as incurred. Total research and development costs were $0 and $83,400 for the nine months ended September 30, 2021 and 2020, respectively.
Advertising Costs	Advertising Costs The Company expenses the cost of advertising and promotional materials when incurred. The advertising costs were $114,673 and $116,951 for the nine months ended September 30, 2021 and 2020, respectively.
Property and Equipment	Property and Equipment Property and equipment are stated at cost. Gain or loss is recognized upon disposal of property and equipment, and the asset and related accumulated depreciation are removed from the accounts. Expenditures for maintenance and repairs are charged to expense as incurred, while expenditures for addition and betterment are capitalized. Furniture and equipment are depreciated on the straight-line method and include the following categories: Estimated Life Machinery and equipment 5-10 years Furniture, fixtures and computer equipment 5-7 years Vehicles 3-5 years Leasehold improvements 2-5 years Long-lived assets held and used by the Company are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. In the event that facts and circumstances indicate that the cost of any long-lived assets may be impaired, an evaluation of recoverability would be performed following generally accepted accounting principles. Depreciation expense during the nine months ended September 30, 2021 and 2020, was $34,034 and $39,892, respectively.
Inventory	Inventory The Company expenses inventory on a first in, first out basis, and had raw materials of $2,850 and $0 as of September 30, 2021 and December 31, 2020, respectively.
Stock-Based Compensation	Stock-Based Compensation The Company periodically issues stock options and warrants to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for stock option and warrant grants issued and vesting to employees based on the authoritative guidance provided by the Financial Accounting Standards Board whereas the value of the award is measured on the date of grant and recognized over the vesting period. The Company accounts for stock option and warrant grants issued and vesting to non-employees in accordance with the authoritative guidance of the Financial Accounting Standards Board whereas the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges generally are amortized over the vesting period on a straight-line basis. In certain circumstances where there are no future performance requirements by the non-employee, option grants are immediately vested and the total stock-based compensation charge is recorded in the period of the measurement date.
Accounting for Derivatives	Accounting for Derivatives The Company evaluates all of its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a probability weighted average series Binomial lattice option pricing models to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date.
Fair Value of Financial Instruments	Fair Value of Financial Instruments Fair Value of Financial Instruments, requires disclosure of the fair value information, whether or not recognized in the balance sheet, where it is practicable to estimate that value. As of September 30, 2021, the balances reported for cash, contract receivables, cost in excess of billing, prepaid expenses, accounts payable, billing in excess of cost, and accrued expenses approximate the fair value because of their short maturities. We adopted ASC Topic 820 for financial instruments measured as fair value on a recurring basis. ASC Topic 820 defines fair value, established a framework for measuring fair value in accordance with accounting principles generally accepted in the United States and expands disclosures about fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 established a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include: ● Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. The following table presents certain investments and liabilities of the Company’s financial assets measured and recorded at fair value on the Company’s balance sheets on a recurring basis and their level within the fair value hierarchy as of September 30, 2021. Total (Level 1) (Level 2) (Level 3) Investment at fair value-securities $ 40,000 $ 40,000 $ - $ - Total Assets measured at fair value $ 40,000 $ 40,000 $ - $ - Total (Level 1) (Level 2) (Level 3) Derivative Liability, September 30, 2021 $ 16,511,716 $ - $ - $ 16,511,716 Total liabilities measured at fair value $ 16,511,716 $ - $ - $ 16,511,716 The following is a reconciliation of the derivative liability for which level 3 inputs were used in determining the approximate fair value: Balance as of January 1, 2021 $ 12,310,307 Fair value at issuance 54,652 Loss on conversion of debt and change in derivative liability 4,146,757 Balance as of September 30, 2021 $ 16,511,716 For purpose of determining the fair market value of the derivative liability, the Company used Binomial lattice formula valuation model. The significant assumptions used in the Binomial lattice formula valuation of the derivative are as follows: 9/30/2021 Risk free interest rate .05% - .28% Stock volatility factor 43.0% - 182.0% Weighted average expected option life 0 months - 5 years Expected dividend yield None
Segment Reporting	Segment Reporting The Company’s business currently operates in one segment based upon the Company’s organizational structure and the way in which the operations are managed and evaluated.
Marketable Securities	Marketable Securities The Company adopted ASU 2016-01, “Financial Instruments – Recognition and Measurement of Financial Assets and Financial Liabilities.” ASU 2016-01 requires investments (except those accounted for under the equity method of accounting, or those that result in consolidation of the investee) to be measured at fair value with changes in fair value recognized in net income. It requires public business entities to use the exit price notion when measuring the fair value of financial instruments for disclosure purpose, and separate presentation of financial assets and financial liabilities by measurement category and form of financial asset. It eliminates the requirement for public business entities to disclose the method(s) and significant assumptions used to estimate the fair value that is required to be disclosed for financial instruments measured at amortized cost. The Company has evaluated the potential impact this standard may have on the condensed consolidated financial statements and determined that it had a significant impact on the condensed consolidated financial statements. The Company accounts for its investment in Water Technologies International, Inc. as available-for-sale securities, and the unrealized gain on the available-for-sale securities is recognized in net income.
Licensing agreement	Licensing agreement The Company analyzed the licensing agreement using ASU 606 to determine the timing of revenue recognition. The licensing of the intellectual property (IP) is distinct from the non-license goods or services and has significant standalone functionality that provides a benefit or value. The functionality will not change during the license period due to the licensor’s activities. Because the significant standalone functionality is delivered immediately, the revenue is generally recognized when the license is delivered.
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements In August 2017, FASB issued accounting standards update ASU-2017-12, “D” (Topic 815) – “Targeted Improvements to Accounting for Hedging Activities”, to require an entity to present the earnings effect of the hedging instrument in the same statement line item in which the earnings effect of the hedged item is reported. The amendments in this update are effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2019, and interim periods with the fiscal years beginning after December 15, 2020. Early adoption is permitted in any interim period after issuance of the update. The Company has evaluated the impact of the adoption of ASU 2017-12 on the Company’s audited consolidated financial statements, which had no material impact. In September 2018, FASB issued accounting standards update ASU 2018-07, (Topic 505) – “Shared-Based Payment Arrangements with Nonemployees”, which simplifies the accounting for share-based payments granted to nonemployees for goods and services. Under the ASU, most of the guidance on such payments to nonemployees will be aligned with the requirements for share-based payments granted to employees. Under the ASU 2018-07, the measurement of equity-classified nonemployee share-based payments will be fixed on the grant date, as defined in ASC 718, and will use the term nonemployee vesting period, rather than requisite service period. The amendments in this update are effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. Early adoption is permitted if financial statements have not yet been issued. The Company adopted ASU 2018-07 on the January 1, 2019. The adoption of the new standard did not have a material impact on the Company’s condensed consolidated financial statements. Management reviewed currently issued pronouncements and does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the accompanying condensed financial statements.

Summary of Significant Accoun_2

Summary of Significant Accounting Polices (Tables)	9 Months Ended
	Sep. 30, 2021
Accounting Policies [Abstract]
Schedule of loss per share anti-dilutive effect	For the Nine months Ended 2021 2020 (Loss) Income to common shareholders (Numerator) $ (12,401,812 ) $ 20,344,331 Basic weighted average number of common shares outstanding (Denominator) 147,762,596 11,598,453 Diluted weighted average number of common shares outstanding (Denominator) 147,762,596 139,029,918
Schedule of issuable shares from warrants, convertible notes and preferred stock	September 30, 2021 Anti-dilutive Dilutive Warrant shares 215,478,283 Convertible debt shares 11,460,000 381,025,971 Preferred shares 33,037,213 - September 30, 2020 Warrant shares 122,044 - Convertible debt shares 17,954,000 262,076,475 Preferred shares 34,037,213 -
Schedule of estimated useful life	Estimated Life Machinery and equipment 5-10 years Furniture, fixtures and computer equipment 5-7 years Vehicles 3-5 years Leasehold improvements 2-5 years
Schedule of fair value of (liability) financial instruments	Total (Level 1) (Level 2) (Level 3) Investment at fair value-securities $ 40,000 $ 40,000 $ - $ - Total Assets measured at fair value $ 40,000 $ 40,000 $ - $ - Total (Level 1) (Level 2) (Level 3) Derivative Liability, September 30, 2021 $ 16,511,716 $ - $ - $ 16,511,716 Total liabilities measured at fair value $ 16,511,716 $ - $ - $ 16,511,716
Schedule of reconciliation of the derivative liability for which level 3 inputs	Balance as of January 1, 2021 $ 12,310,307 Fair value at issuance 54,652 Loss on conversion of debt and change in derivative liability 4,146,757 Balance as of September 30, 2021 $ 16,511,716
Schedule of fair market value of derivative liability assumptions	9/30/2021 Risk free interest rate .05% - .28% Stock volatility factor 43.0% - 182.0% Weighted average expected option life 0 months - 5 years Expected dividend yield None

Restricted Stock and Warrants (

Restricted Stock and Warrants (Tables)	9 Months Ended
	Sep. 30, 2021
Share-based Payment Arrangement [Abstract]
Schedule of warrant activity	2021 Weighted average Number of exercise Warrants price Outstanding - beginning of period 15,922,044 $ 4.24 Granted 200,678,283 $ 0.07 Exercised (1,000,000 ) $ 0.05 Forfeited (122,044 ) $ (4.17 ) Outstanding - end of period 215,478,283 $ 0.07
Schedule of weighted average remaining contractual life of warrants outstanding	2021 Weighted Remaining Exercise Warrants Warrants Contractual Prices Outstanding Exercisable Life (years) $ 0.05 136,498,340 136,498,340 0.13 - 99 $ 0.02 600,000 600,000 4.92 $ 0.10 64,827,670 64,827,670 0.13 - 0.99 $ 0.25 3,860,000 3,860,000 1.75 - 1.99 $ 0.0275 8,727,273 8,727,273 9.66 $ 1.00 965,000 965,000 2.75 - 2.99 215,478,283 215,478,283

Convertible Promissory Notes (T

Convertible Promissory Notes (Tables)	9 Months Ended
	Sep. 30, 2021
Debt Disclosure [Abstract]
Schedule of outstanding convertible promissory notes	Convertible Promissory Notes, net of discount $ 3,061,761 Less current portion 2,999,486 Total long-term liabilities $ 62,275
Schedule of maturities of long-term debt	Period Ended September Amount 2022 $ 3,019,780 2023 62,275 $ 3,082,055

Revenue from Contracts with C_2

Revenue from Contracts with Customers (Tables)	9 Months Ended
	Sep. 30, 2021
Revenue From Contracts With Customers [Abstract]
Schedule of disaggregation of revenue by type of good or service from contracts with customers	Nine months Ended September 30, 2021 2020 Equipment Contracts $ 1,903,190 $ 1,879,727 Component Sales 841,203 1,076,574 Services Sales 82,634 108,457 Rental Income 21,260 - $ 2,848,287 $ 3,064,758

Capital Leases (Tables)

Capital Leases (Tables)	9 Months Ended
	Sep. 30, 2021
Capital Leases [Abstract]
Schedule of maturities	Capital lease $ 10,257 Less current portion 9,088 Total long-term liabilities $ 1,169

Organization and Line of Busi_2

Organization and Line of Business (Details)	9 Months Ended
	Sep. 30, 2021USD ($)
Accounting Policies [Abstract]
Contribution of Property	$ 464,000
Revenue	$ 2,848,287

Summary of Significant Accoun_3

Summary of Significant Accounting Polices (Details) - USD ($)	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Accounting Policies [Abstract]
Contract receivable	$ 712,006		$ 438,430
Research and development costs	0	$ 83,400
Advertising costs	114,673	116,951
Depreciation expense	34,034	$ 39,892
Raw materials	$ 2,850		$ 0

Summary of Significant Accoun_4

Summary of Significant Accounting Polices (Details) - Schedule of loss per share anti-dilutive effect - USD ($)	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Schedule of loss per share anti-dilutive effect [Abstract]
(Loss) Income to common shareholders (Numerator) (in Dollars)	$ (12,401,812)	$ 20,344,331
Basic weighted average number of common shares outstanding (Denominator)	147,762,596	11,598,453
Diluted weighted average number of common shares outstanding (Denominator)	147,762,596	139,029,918

Summary of Significant Accoun_5

Summary of Significant Accounting Polices (Details) - Schedule of issuable shares from warrants, convertible notes and preferred stock - shares	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Warrant shares [Member]
Conversion of Stock [Line Items]
Anti-dilutive shares		122,044
Dilutive shares	215,478,283
Convertible debt shares [Member]
Conversion of Stock [Line Items]
Anti-dilutive shares	11,460,000	17,954,000
Dilutive shares	381,025,971	262,076,475
Preferred shares [Member]
Conversion of Stock [Line Items]
Anti-dilutive shares	33,037,213	34,037,213
Dilutive shares

Summary of Significant Accoun_6

Summary of Significant Accounting Polices (Details) - Schedule of estimated useful life	9 Months Ended
	Sep. 30, 2021
Minimum [Member] | Machinery and equipment [Member]
Summary of Significant Accounting Polices (Details) - Schedule of estimated useful life [Line Items]
Estimated Life	5 years
Minimum [Member] | Furniture, fixtures and computer equipment [Member]
Summary of Significant Accounting Polices (Details) - Schedule of estimated useful life [Line Items]
Estimated Life	5 years
Minimum [Member] | Vehicles [Member]
Summary of Significant Accounting Polices (Details) - Schedule of estimated useful life [Line Items]
Estimated Life	3 years
Minimum [Member] | Leasehold improvements [Member]
Summary of Significant Accounting Polices (Details) - Schedule of estimated useful life [Line Items]
Estimated Life	2 years
Maximum [Member] | Machinery and equipment [Member]
Summary of Significant Accounting Polices (Details) - Schedule of estimated useful life [Line Items]
Estimated Life	10 years
Maximum [Member] | Furniture, fixtures and computer equipment [Member]
Summary of Significant Accounting Polices (Details) - Schedule of estimated useful life [Line Items]
Estimated Life	7 years
Maximum [Member] | Vehicles [Member]
Summary of Significant Accounting Polices (Details) - Schedule of estimated useful life [Line Items]
Estimated Life	5 years
Maximum [Member] | Leasehold improvements [Member]
Summary of Significant Accounting Polices (Details) - Schedule of estimated useful life [Line Items]
Estimated Life	5 years

Summary of Significant Accoun_7

Summary of Significant Accounting Polices (Details) - Schedule of fair value of (liability) financial instruments - USD ($)	Sep. 30, 2021	Dec. 31, 2020
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investment at fair value-securities	$ 40,000
Total Assets measured at fair value	40,000
Derivative Liability, September 30, 2021	16,511,716	$ 12,310,307
Total liabilities measured at fair value	16,511,716
Level 1 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investment at fair value-securities	40,000
Total Assets measured at fair value	40,000
Derivative Liability, September 30, 2021
Total liabilities measured at fair value
Level 2 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investment at fair value-securities
Total Assets measured at fair value
Derivative Liability, September 30, 2021
Total liabilities measured at fair value
Level 3 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investment at fair value-securities
Total Assets measured at fair value
Derivative Liability, September 30, 2021	16,511,716
Total liabilities measured at fair value	$ 16,511,716

Summary of Significant Accoun_8

Summary of Significant Accounting Polices (Details) - Schedule of reconciliation of the derivative liability for which level 3 inputs	9 Months Ended
	Sep. 30, 2021USD ($)
Schedule of reconciliation of the derivative liability for which level 3 inputs [Abstract]
Balance as of January 1, 2021	$ 12,310,307
Fair value at issuance	54,652
Loss on conversion of debt and change in derivative liability	4,146,757
Balance as of September 30, 2021	$ 16,511,716

Summary of Significant Accoun_9

Summary of Significant Accounting Polices (Details) - Schedule of fair market value of derivative liability assumptions	9 Months Ended
	Sep. 30, 2021
Summary of Significant Accounting Polices (Details) - Schedule of fair market value of derivative liability assumptions [Line Items]
Expected dividend yield	0.00%
Minimum [Member]
Summary of Significant Accounting Polices (Details) - Schedule of fair market value of derivative liability assumptions [Line Items]
Risk free interest rate	5.00%
Stock volatility factor	43.00%
Weighted average expected option life	0 months
Maximum [Member]
Summary of Significant Accounting Polices (Details) - Schedule of fair market value of derivative liability assumptions [Line Items]
Risk free interest rate	28.00%
Stock volatility factor	182.00%
Weighted average expected option life	5 years

Capital Stock (Details)

Capital Stock (Details) - USD ($)	Sep. 16, 2021	Aug. 10, 2021	May 26, 2021	Apr. 28, 2021	Mar. 01, 2021	Feb. 24, 2021	Feb. 05, 2021	Nov. 16, 2020	Aug. 21, 2020	Jul. 01, 2020	Apr. 27, 2020	Jun. 03, 2019	Apr. 03, 2019	Jan. 16, 2019	Aug. 14, 2018	Apr. 13, 2018	Mar. 14, 2017	Aug. 28, 2021	Jun. 10, 2021	Sep. 30, 2021	Dec. 31, 2020	Sep. 13, 2021	Jun. 30, 2021	Oct. 19, 2020	Sep. 30, 2020	Dec. 31, 2019
Capital Stock (Details) [Line Items]
Common stock, shares issued																				225,980,190	65,052,688
Redemption of Preferred Stock																			$235,000
Redeem shares																		581
Aggregate of shares																		120
Aggregate of redemption price (in Dollars)																		$ 120,000
Issuance of common stock, shares																				119,049,835
Aggregate shares																				27,357,198
Aggregate purchase price, shares																				29,425
Shares issued aggregate																				495,366
Fair value (in Dollars)																				$ 11,181,822
Exercise price (in Dollars per share)																				$ 0.1
Common stock par value (in Dollars per share)																				$ 0.0001	$ 0.0001
Long term asset for sale (in Dollars)																				$ 514,000		$ 514,000
Sale of property descriptions																				The Company has actively listed the residential real property for sale and on September 13, 2021, received an offer for the property for $464,000, which is $116,000 below the original independent appraisal of $580,000. The offer was accepted and the Company is currently completing all formalities required to close the transaction. Based on the above indicator of impairment, during the quarter ended September 30, 2021, the Company adjusted the original value of the long term asset for sale from $630,000 to $514,000 on the balance sheet and recorded an impairment of $116,000 in the consolidated statement of operations.
Common stock shares outstanding		0.0999																		225,980,190	65,052,688
Recognized loss (in Dollars)		$ 125,000
Common stock, shares authorized																				16,000,000,000	16,000,000,000
Interest amount (in Dollars)																				$ 37,494
Common stock issued for services, shares																				24,656,117
Common stock issued for services fair value (in Dollars)																				$ 1,931,222
Common stock upon conversion of preferred stock																				70
Warrant exercise price (in Dollars per share)																				$ 0.05
Warrant exercise price received (in Dollars per share)																				$ 50,000
Settlement fees (in Dollars)																				$ 126,064
Recognized loss conversion of shares																				1,033
Series C Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Voting power																	51%
Preferred stock per share (in Dollars per share)																	$ 0.0001
Purchase price of the series C preferred stock (in Dollars per share)																	$ 0.1
Total purchase price series C preferred stock, shares																	1,000
Preferred stock shares outstanding																				1,000
Preferred stock, share authorized																				550,000,000	550,000,000
Preferred stock issued																				1,000	1,000
Preferred stock per share (in Dollars per share)																				$ 0.0001	$ 0.0001
Preferred stock shares outstanding																				1,000	1,000
Series C Preferred Stock [Member] | Board of Directors [Member]
Capital Stock (Details) [Line Items]
Shares issued																	1,000
Series D-1 Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Preferred stock, share authorized																50,000,000
Convertible preferred stock, per share (in Dollars per share)																$ 0.0005
Percentage of common stock outstanding																4.99%
Increased common stock percentage																9.99%
Common stock, shares issued																				68,571
Conversion of preferred shares																				1,000,000
Preferred stock issued																				31,500,000
Series E Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Preferred stock, share authorized															4,000,000
Convertible preferred stock, per share (in Dollars per share)															$ 0.05
Percentage of common stock outstanding															4.99%
Increased common stock percentage															9.99%
Preferred stock issued																				1,537,213	1,537,213
Preferred stock shares outstanding																				1,537,213	1,537,213
Issuance of common stock, shares																				30,124
Common stock upon conversion of preferred stock																				602,436
Series F Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Preferred stock shares outstanding																					275
Preferred stock issued																					275
Designated preferred stock issued															6,000
Preferred stock liquidation per share (in Dollars per share)															$ 1,000
Annual rate percentage															8.00%
Aggregate preferred stock, share issued																				15	1,278			125
Preferred stock, description																					a holder of 100 of such outstanding shares of Series F preferred stock, agreed that the Company would have no obligation to redeem such holder’s shares of Series F preferred stock prior to September 1, 2022, and the Company agreed to pay such holder, in addition to any dividends payable on such holder’s Series F preferred stock, an annual fee of 4% of the stated value of such holder’s shares of Series F preferred stock. During the nine months ended September 30, 2021, 15 shares of Series F preferred stock were exchanged for 15 shares of Series Q preferred stock and no gain or loss was recognized Excluding the 100 shares mentioned above, as of September 30, 2021, the Company had 160 outstanding shares of Series F preferred stock which the Company was required to, and failed to redeem on September 1, 2020, and was in default for an aggregate redemption price (equal to the stated value) of $160,000.
Series Q Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Percentage of common stock outstanding									4.99%
Preferred stock issued																				620
Designated preferred stock issued									2,000
Aggregate preferred stock, share issued																				15	1,278
Preferred stock per share (in Dollars per share)									$ 1,000
Dividend rate, percentage									12.00%
Percentage of common stock									200.00%
Common stock outstanding increased percentage									9.99%
Aggregate shares (in Dollars)																				$ 10,668,656
Common stock shares conversion																				420
Series O Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Preferred stock per share (in Dollars per share)											$ 1,000
Common stock, shares issued																				166,990
Preferred stock issued																				815
Designated preferred stock issued											2,000
Aggregate preferred stock, share issued																				120				125
Aggregate preferred stock, share issued																				120
Conversion price percentage											200.00%
Conversion of shares																				1,060
Percentage of common stock																				4.00%
Series P Preferred Stocks Member
Capital Stock (Details) [Line Items]
Increased common stock percentage											9.99%
Preferred stock issued																				76
Designated preferred stock issued											500
Aggregate preferred stock, share issued																								31
Preferred stock per share (in Dollars per share)											$ 1,000
Conversion of stock (in Dollars)																				$ 335,081
Preferred stock shares outstanding																				76
Conversion of shares																				280
Percentage of common stock											4.99%
Aggregate shares																				9,720,267
Series G Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Shares issued																				50
Designated preferred stock issued														6,000
Annual rate percentage														8.00%
Aggregate preferred stock, share issued																				365
Preferred stock per share (in Dollars per share)														$ 1,000
Divided closing price (in Dollars)														$ (500)
Preferred stock were exchanged																				380
Shares outstanding																				50,000
Series S Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Preferred stock per share (in Dollars per share)							$ 1,000
Percentage of common stock outstanding							4.99%
Increased common stock percentage							9.99%
Common stock, shares issued																				5,495,406
Preferred stock issued																				170
Designated preferred stock issued							430
Aggregate preferred stock, share issued																				365
Preferred stock were exchanged																				365
Dividend rate, percentage							12.00%
Percentage of common stock							200.00%
Conversion price (in Dollars per share)																				$ 195
Series R Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Shares issued																				4,280
Percentage of common stock outstanding								4.99%
Common stock, shares issued																				1,000,000
Preferred stock issued																				15
Designated preferred stock issued								5,000
Aggregate preferred stock, share issued																				120
Preferred stock per share (in Dollars per share)								$ 1,000
Dividend rate, percentage								10.00%
Exchange of shares																				317
Preferred stock, shares issued																				120
Purchase price of shares																				1,822
Aggregate shares																				15
Exchange amount (in Dollars)																				$ 40,000
Percentage of common stock								200.00%
Common stock outstanding increased percentage								9.99%
Aggregate shares (in Dollars)																				$ 33,520,261
Aggregate shares																				2,481
Aggregate purchase price																				2,480,750
Conversion of stock, share converted																				1,085
Fair value (in Dollars)																				$ 0.05
Common stock exercise price (in Dollars per share)																				$ 1,000,000
Series R Preferred Stock [Member] | Series R Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Preferred stock issued																				111,298,340
Preferred stock shares outstanding																				55,177,670
Series W Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Shares issued																				235
Preferred stock per share (in Dollars per share)													$ 1,000
Preferred stock issued																				235	797
Designated preferred stock issued													4,000
Shares outstanding																				235
Dividend rate, percentage													8.00%
Aggregate preferred stock, share issued																				562
Preferred stock shares outstanding																				235	797
Aggregate shares																				317
Series W Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Common stock, shares issued																				1,798,562
Preferred stock issued				3,390																758
Annual rate percentage				12.00%
Preferred stock per share (in Dollars per share)				$ 1,000
Preferred stock, shares issued																				245
Preferred stock shares outstanding																				758
Shares exchange																				758
Stated value percentage				200.00%
Outstanding common stock percentage				4.99%
Amount of accrued dividends (in Dollars)																				$ 359,267
Series J Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Preferred stock per share (in Dollars per share)													$ 1,000
Common stock, shares issued																				1,203,924
Preferred stock issued																				225
Designated preferred stock issued													100,000
Conversion of shares																				47.5
Conversion of stock (in Dollars)																				$ 64,889
Preferred stock shares outstanding																				225
Series K Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Preferred stock per share (in Dollars per share)												$ 1,000
Preferred stock issued																				581	3,160
Designated preferred stock issued												4,000
Aggregate preferred stock, share issued																				1,822
Preferred stock shares outstanding																				581	3,160
Purchase price of shares																				2,580
Series M Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Designated preferred stock issued										800,000
Aggregate preferred stock, share issued																				3,200
Dividend rate, percentage										10.00%		8.00%
Conversion of shares																					320
Preferred stock shares outstanding																				40,340
Issuance of common stock, shares																				137,052	137,052
Preferred stock stated value (in Dollars)										$ 25
Liquidation preference value (in Dollars)										$ 25
Redemption price, per share (in Dollars per share)										$ 37.5
Stated value percentage										150.00%
Aggregate shares																				1,177
Aggregate purchase price, shares																				3,200
Series L Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Preferred stock per share (in Dollars per share)												$ 1,000
Preferred stock issued																				660
Designated preferred stock issued												100,000
Conversion of shares																				472
Conversion of stock (in Dollars)																				$ 740,696
Issuance of common stock, shares																				15,265,754
Series T Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Shares issued																				630
Preferred stock per share (in Dollars per share)						$ 1,000
Percentage of common stock outstanding						4.99%
Preferred stock issued																				25,200,000
Designated preferred stock issued						630
Dividend rate, percentage						10.00%
Common stock outstanding increased percentage						9.99%
Common stock par value (in Dollars per share)					$ 0.05
Annual dividends, percentage					10.00%
Real property cost (in Dollars)					$ 630,000
Property consists of residential real estate (in Dollars)					580,000
Undeveloped lots valued (in Dollars)					$ 50,000
Long term asset for sale (in Dollars)																				$ 630,000
Preferred stock valued (in Dollars)																				$ 2,037,849
Series T Preferred Stock [Member] | Securities Purchase Agreement [Member]
Capital Stock (Details) [Line Items]
Aggregate purchase price, shares					630
Agreed of purchase warrants					630
Warrants shares (in Dollars)					$ 25,200,000
Series U preferred stock [Member]
Capital Stock (Details) [Line Items]
Shares issued																				965
Percentage of common stock outstanding			4.99%
Common stock, shares issued																				330
Designated preferred stock issued			5,000
Aggregate preferred stock, share issued																				7,020,764
Preferred stock per share (in Dollars per share)			$ 1,000
Preferred stock shares outstanding																							635
Aggregate shares																				8,729,034
Percentage of common stock			150.00%
Common stock outstanding increased percentage			9.99%
Common stock par value (in Dollars per share)			$ 0.2
Conversion price percentage			200.00%
Convertible preferred stock, redeemable value (in Dollars)																				$ 965,000
Conversion of common stock																				246
Series V Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Percentage of common stock outstanding	4.99%
Designated preferred stock issued	3,000
Preferred stock per share (in Dollars per share)	$ 100,000
Common stock outstanding increased percentage	9.99%
Annual net profits percentage	25.00%
Subsidiary’s annual net profits percentage	25.00%
Series X Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Designated preferred stock issued		25
Preferred stock per share (in Dollars per share)		$ 10,000
Percentage of common stock		250.00%
Common stock shares outstanding		0.0499
Subscription agreement percentage		125.00%
Subscription agreement (in Dollars)		$ 250,000
Original purchase price (in Dollars)		312,500
Common stock purchase price (in Dollars)		250,000
Divided price (in Dollars)		$ 625,000
Sale of aggregate shares		25
Aggregate purchase price (in Dollars)		$ 250,000
Aggregate common stock shares		1,798,562
Warrant exercise price (in Dollars per share)																				$ 0.0695
Company loss (in Dollars)																				$ 125,000
Maximum [Member]
Capital Stock (Details) [Line Items]
Conversion price (in Dollars per share)																				$ 0.124
Maximum [Member] | Series O Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Annual rate percentage											8.00%
Outstanding common stock percentage											9.99%
Minimum [Member]
Capital Stock (Details) [Line Items]
Conversion price (in Dollars per share)																				$ 0.0351
Minimum [Member] | Series O Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Annual rate percentage											4.00%
Outstanding common stock percentage											4.99%
Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Shares outstanding																				33,038,213	34,038,213				34,037,213	40,674,799
Preferred Stock [Member] | Series R Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Preferred stock issued																				2,394
Preferred Stock [Member] | Series W Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Preferred stock issued																				245
Preferred Stock [Member] | Series W Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Preferred stock issued																				1,003
Preferred Stock [Member] | Series K Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Preferred stock issued																				758
Common Stock [Member]
Capital Stock (Details) [Line Items]
Common stock, shares issued																				295,141
Shares outstanding																				225,980,190	65,052,688				31,436,122	4,854,993
Fair value (in Dollars)																				$ 23,778
Conversion price (in Dollars per share)																				$ 0.00955
common stock share issued																				13,927,622
Aggregate principal amount (in Dollars)																				$ 81,150
Interest amount (in Dollars)																				$ 52,555
Common stock issued for services, shares																				3,297,275
Common stock issued for services fair value (in Dollars)																				$ 263,997
Common stock for preferred stock dividends payable																				495,366
Common stock upon conversion of preferred stock																				12,086
Common stock for the settlement of convertible promissory notes																				9,732,328
Aggregate principal amount (in Dollars)																				$ 114,612
Conversion share of amount (in Dollars)																				$ 29,188
Common Stock [Member] | Series D-1 Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Conversion of preferred shares																				6,000,000
Common Stock [Member] | Series J Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Issuance of common stock, shares																				2,313,689
Common Stock [Member] | Series M Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Aggregate preferred stock, share issued																				320
Common Stock [Member] | Series L Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Aggregate preferred stock, share issued																				284
Issuance of common stock, shares																				10,038,055
Common Stock [Member] | Maximum [Member]
Capital Stock (Details) [Line Items]
Conversion price (in Dollars per share)																				$ 0.05
Common Stock [Member] | Minimum [Member]
Capital Stock (Details) [Line Items]
Conversion price (in Dollars per share)																				$ 0.025

Restricted Stock and Warrants_2

Restricted Stock and Warrants (Details) - USD ($)	Sep. 14, 2021	Mar. 01, 2021	Aug. 14, 2019	Sep. 30, 2021
Restricted Stock and Warrants (Details) [Line Items]
Aggregate shares of common stock				119,049,835
Preferred stocks realized				$ 50,000
Warrants exercise				1,000,000
Warrant exercise price				$ 0.05
Issueance of common stock				$ 9,327,273
Stock compensation expense				62,480
Warrants outstanding				$ 269,197
Restricted Stock Grant Agreement [Member] | Employee Consultants and Restricted Stock Grant Agreements [Member]
Restricted Stock and Warrants (Details) [Line Items]
Restricted stock grant agreement, description	a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period as reported in the Company’s quarterly or annual financial statements, the Company will issue up to an aggregate of 109,070,842 shares of its common stock; b) If the Company’s consolidated operating profit Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported as reported in the Company’s SEC reports, the Company will issue up to an aggregate of 109,070,842 shares of its common stock. The Company has not recognized any costs associated with the milestones, because achievement is not probable.
Issuance of common stock to employees	218,141,685
Vesting period			2 years
Aggregate of common stock, percentage			5.00%
Mr. T. Riggs Eckelberry [Member]
Restricted Stock and Warrants (Details) [Line Items]
Aggregate shares of common stock				2,771,892
Common stock value				$ 211,520
Warrant [Member]
Restricted Stock and Warrants (Details) [Line Items]
Warrants issued				200,678,283
Chief Executive Officer [Member] | Restricted Stock Grant Agreement [Member]
Restricted Stock and Warrants (Details) [Line Items]
Restricted stock grant agreement, description		The RSGAs provides for the issuance of up to an aggregate of 202,109,214 shares of the Company’s common stock to Mr. Eckelberry provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period as reported in the Company’s quarterly or annual financial statements, the Company will issue up to an aggregate of 101,054,607 shares of its common stock; b) If the Company’s consolidated operating profit (Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported as reported in the Company’s SEC Reports, the Company will issue up to an aggregate of 101,054,607 shares of its common stock.
Aggregate shares of common stock		202,109,214

Restricted Stock and Warrants_3

Restricted Stock and Warrants (Details) - Schedule of warrant activity - Warrant [Member]	9 Months Ended
	Sep. 30, 2021$ / sharesshares
Restricted Stock and Warrants (Details) - Schedule of warrant activity [Line Items]
Number of Warrants, Outstanding - beginning of period | shares	15,922,044
Weighted average exercise price, Outstanding - beginning of period | $ / shares	$ 4.24
Number of Warrants, Granted | shares	200,678,283
Weighted average exercise price, Granted | $ / shares	$ 0.07
Number of Warrants, Exercised | shares	(1,000,000)
Weighted average exercise price, Exercised | $ / shares	$ 0.05
Number of Warrants, Forfeited | shares	(122,044)
Weighted average exercise price, Forfeited | $ / shares	$ (4.17)
Number of Warrants, Outstanding - end of period | shares	215,478,283
Weighted average exercise price, Outstanding - end of period | $ / shares	$ 0.07

Restricted Stock and Warrants_4

Restricted Stock and Warrants (Details) - Schedule of weighted average remaining contractual life of warrants outstanding	9 Months Ended
	Sep. 30, 2021$ / sharesshares
Class of Warrant or Right [Line Items]
Warrants Outstanding	215,478,283
Warrants Exercisable	215,478,283
0.05 [Member]
Class of Warrant or Right [Line Items]
Exercise Prices (in Dollars per share) | $ / shares	$ 0.05
Warrants Outstanding	136,498,340
Warrants Exercisable	136,498,340
0.02 [Member]
Class of Warrant or Right [Line Items]
Exercise Prices (in Dollars per share) | $ / shares	$ 0.02
Warrants Outstanding	600,000
Warrants Exercisable	600,000
Weighted Average Remaining Contractual Life (years)	4 years 11 months 1 day
0.10 [Member]
Class of Warrant or Right [Line Items]
Exercise Prices (in Dollars per share) | $ / shares	$ 0.1
Warrants Outstanding	64,827,670
Warrants Exercisable	64,827,670
0.25 [Member]
Class of Warrant or Right [Line Items]
Exercise Prices (in Dollars per share) | $ / shares	$ 0.25
Warrants Outstanding	3,860,000
Warrants Exercisable	3,860,000
0.275 [Member]
Class of Warrant or Right [Line Items]
Exercise Prices (in Dollars per share) | $ / shares	$ 0.0275
Warrants Outstanding	8,727,273
Warrants Exercisable	8,727,273
Weighted Average Remaining Contractual Life (years)	9 years 7 months 28 days
1.00 [Member]
Class of Warrant or Right [Line Items]
Exercise Prices (in Dollars per share) | $ / shares	$ 1
Warrants Outstanding	965,000
Warrants Exercisable	965,000
Minimum [Member] | 0.05 [Member]
Class of Warrant or Right [Line Items]
Weighted Average Remaining Contractual Life (years)	1 month 17 days
Minimum [Member] | 0.10 [Member]
Class of Warrant or Right [Line Items]
Weighted Average Remaining Contractual Life (years)	1 month 17 days
Minimum [Member] | 0.25 [Member]
Class of Warrant or Right [Line Items]
Weighted Average Remaining Contractual Life (years)	1 year 9 months
Minimum [Member] | 1.00 [Member]
Class of Warrant or Right [Line Items]
Weighted Average Remaining Contractual Life (years)	2 years 9 months
Maximum [Member] | 0.05 [Member]
Class of Warrant or Right [Line Items]
Weighted Average Remaining Contractual Life (years)	99 years
Maximum [Member] | 0.10 [Member]
Class of Warrant or Right [Line Items]
Weighted Average Remaining Contractual Life (years)	11 months 26 days
Maximum [Member] | 0.25 [Member]
Class of Warrant or Right [Line Items]
Weighted Average Remaining Contractual Life (years)	1 year 11 months 26 days
Maximum [Member] | 1.00 [Member]
Class of Warrant or Right [Line Items]
Weighted Average Remaining Contractual Life (years)	2 years 11 months 26 days

Convertible Promissory Notes (D

Convertible Promissory Notes (Details) - USD ($)	Jan. 25, 2021	Mar. 13, 2019	Jan. 01, 2016	Nov. 19, 2020	Sep. 30, 2021	Sep. 30, 2019	May 31, 2018	Apr. 02, 2018
Convertible Promissory Notes (Details) [Line Items]
Convertible promissory notes					$ 3,082,055
Net of debt discount					20,294
Net balance					3,061,761
Derivative liabilities					$ 16,511,716
Unsecured Convertible Promissory Note [Member]
Convertible Promissory Notes (Details) [Line Items]
Conversion price per share of debt, description					The Apr & May 2018 Notes had maturity dates of April 2, 2019 and May 31, 2019, respectively. The Apr & May 2018 Notes bear interest at 10% per year. The Apr & May 2018 Notes may be converted into shares of the Company’s common stock at a variable conversion price of 50% of the lesser of the lowest trading price twenty-five (25) trading days prior to conversion.
Issued shares of common stock (in Shares)						12,500
Converted an aggregate principal amount						$ 6,523
Accrued interest						4,727
Aggregate remaining amount					$ 218,064		$ 300,000	$ 300,000
Conversion of fair value loss						$ 16,250
Investor amount		$ 570,000
Reserved shares (in Shares)		2,630,769
Unsecured Convertible Promissory Note [Member] | 2014-2015 Notes [Member]
Convertible Promissory Notes (Details) [Line Items]
Conversion price per share of debt, description					The 2014-2015 Notes bear interest at 10% per year. The 2014-2015 Notes may be converted into shares of the Company’s common stock at conversion prices ranging from the lesser of $4,200 to $9,800 (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or 50% of the lowest trade price on any trade day following issuance of the 2014-2015 Notes.
Issued shares of common stock (in Shares)					13,927,621
Converted an aggregate principal amount					$ 81,150
Accrued interest					52,555
Aggregate remaining amount					$ 930,000
Unsecured Convertible Promissory Note [Member] | 2015-2016 Notes [Member]
Convertible Promissory Notes (Details) [Line Items]
Conversion price per share of debt, description					The 2015-2016 Notes may be converted into shares of the Company’s common stock at conversion prices ranging from the lesser of $1,400 to $5,600 (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or 50% of the lowest trade price on any trade day following issuance of the 2015-2016 Notes.
Aggregate remaining amount					$ 1,200,000
Maturity date					May 19, 2020
Debt instrument interest rate					10.00%
Unsecured Convertible Promissory Note [Member] | Nov 20 Note [Member]
Convertible Promissory Notes (Details) [Line Items]
Aggregate remaining amount					$ 13,772
Maturity date				Nov. 19, 2021
Convertible debt				$ 50,000
Convertible debt received funds				$ 50,000
Bears interest rate				10.00%
Unsecured convertible promissory note, description				The Nov 20 Note may be converted into shares of the Company’s common stock at a lesser price of $0.05 per share or (b) fifty percent (50%) of the lowest trade price of common stock recorded on any trade after the effective date, or (c) the lowest effective price per share granted. In addition, for each conversion, in event that shares are not delivered by the fourth business day (inclusive of the day of conversion), a penalty of $2,000 per day shall be assessed for each day after the third business day until the shares are delivered. The conversion feature of the Nov 20 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Note. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $10,047 during the nine months ended September 30, 2021. During the nine months ended September 30, 2021, the Company paid off $15,228 in cash, of the Nov 20 Note. As of September 30, 2021, the remaining balance of the Nov 20 Note was $13,772, which is short term.The Company entered into an unsecured convertible promissory note (the “Jan 21 Note”), on January 25, 2021 in the amount of $60,000. The Company received funds in the amount of $60,000. The Jan 21 Note matures on January 25, 2022, twelve months from the effective date of the Note. The Note may be extended sixty (60) months from the maturity date. The Jan 21 Note bears interest at 10% per year. The Jan 21 Note may be converted into shares of the Company’s common stock at a conversion price equal to the lower of (a) $0.05 per share, (b) fifty percent (50%) of the lowest trade price of common stock recorded on any trade after the effective date, or (c) the lowest effective price per share granted. In addition, for each conversion, in event that shares are not delivered by the fourth business day (inclusive of the day of conversion), a penalty of $2,000 per day shall be assessed for each day after the third business day until the shares are delivered.
Interest expense					10,047
Cash paid					15,228
Unsecured Convertible Promissory Note [Member] | Jan 21 Note [Member]
Convertible Promissory Notes (Details) [Line Items]
Maturity date	Jan. 25, 2022
Convertible debt	$ 60,000
Convertible debt received funds	$ 60,000
Unsecured convertible promissory note, description	In addition, for each conversion, in event that shares are not delivered by the fourth business day (inclusive of the day of conversion), a penalty of $2,000 per day shall be assessed for each day after the third business day until the shares are delivered.
Interest expense					23,358
Remaining debt amount					$ 60,000
Original Issue Discount Notes [Member]
Convertible Promissory Notes (Details) [Line Items]
Conversion price per share of debt, description					After the amendment, the conversion price changed to the lesser of $5,600 per share, or b) fifty percent (50%) of the lowest trade price of common stock recorded since the original effective date of this note, or c) the lowest effective price per share granted to any person or entity after the effective date.
Accrued interest					$ 13,334
Aggregate remaining amount					184,124
Conversion into common stock					30,620
Long term promissory notes					62,275
Convertible Debt [Member] | Dec 2015 Note [Member]
Convertible Promissory Notes (Details) [Line Items]
Aggregate remaining amount					167,048
Accounts payable					432,048
Percentage of average of lowest closing prices			75.00%
Convertible Debt [Member] | Sep 2016 Note [Member]
Convertible Promissory Notes (Details) [Line Items]
Aggregate remaining amount					430,896
Accounts payable					$ 430,896
Percentage of average of lowest closing prices					75.00%

Convertible Promissory Notes _2

Convertible Promissory Notes (Details) - Schedule of outstanding convertible promissory notes	Sep. 30, 2021USD ($)
Schedule of outstanding convertible promissory notes [Abstract]
Convertible Promissory Notes, net of discount	$ 3,061,761
Less current portion	2,999,486
Total long-term liabilities	$ 62,275

Convertible Promissory Notes _3

Convertible Promissory Notes (Details) - Schedule of maturities of long-term debt	Sep. 30, 2021USD ($)
Schedule of maturities of long-term debt [Abstract]
2022	$ 3,019,780
2023	62,275
Total	$ 3,082,055

Revenue from Contracts with C_3

Revenue from Contracts with Customers (Details) - USD ($)	Sep. 30, 2021	Dec. 31, 2020
Revenue From Contracts With Customers [Abstract]
Contract assets	$ 71,861	$ 148,734
Contract liability	$ 538,706	$ 340,551

Revenue from Contracts with C_4

Revenue from Contracts with Customers (Details) - Schedule of disaggregation of revenue by type of good or service from contracts with customers - Type of Good or Service [Member] - USD ($)	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Disaggregation of Revenue [Line Items]
Equipment Contracts	$ 1,903,190	$ 1,879,727
Component Sales	841,203	1,076,574
Services Sales	82,634	108,457
Rental Income	21,260
Total	$ 2,848,287	$ 3,064,758

Financial Assets (Details)

Financial Assets (Details) - USD ($)	May 15, 2018	Sep. 30, 2021	Dec. 31, 2020
Financial Assets (Details) [Line Items]
Fair value investment in securities description	the Company received 4,000 shares of WTII Series C convertible preferred stock for the use of OriginClear, Inc. technology associated with their proprietary electro water separation system. Each share of Series C convertible preferred stock is convertible into 1,000 shares of WTII common stock. The stock was valued at fair market value of $0.0075 for a price of $30,000 on the date of issuance. The Company analyzed the licensing agreement using ASU 606 to determine the timing of revenue recognition.
Preferred shares fair value		$ 40,000
Convertible Note Receivable [Member]
Financial Assets (Details) [Line Items]
Convertible note percentage		10.00%
Convertible note amount		$ 80,000
Convertible note price percentage		65.00%
Number of trading days		10
Conversion price per share (in Dollars per share)		$ 0.0001
Convertible note principal amount		$ 80,000
Convertible note accrued interest		53,879
Convertible note total		$ 133,879
Convertible Note Receivable [Member] | Business Combination [Member]
Financial Assets (Details) [Line Items]
Convertible note recognized financial amount			$ 133,879

Loans Payable (Details)

Loans Payable (Details) - USD ($)	Sep. 12, 2020	Sep. 30, 2021	Dec. 31, 2020	Sep. 28, 2018
Loans Payable (Details) [Line Items]
Loans payable		$ 157,250
Net balance		80,646	$ 342,896
Notes payable		48,116		$ 248,870
Principal amount		142,999
Payments balance		3,651
Leaving balance		0
Proceeds from loans received	$ 505,000	150,000
Granted loan amount		$ 10,000
Secured Loans Payable [Member]
Loans Payable (Details) [Line Items]
Leaving balance description		short term loans with various lenders for capital expansion secured by the Company’s assets in the amount of $1,749,970, which included finance cost of $624,810. The term of the loans ranged from two months to six months. The finance cost was amortized over the terms of the loans, which had various maturity dates ranging from October 2018 through February 2019. As of December 31, 2019, the finance cost was fully amortized.
Loan Payable-Related Party [Member]
Loans Payable (Details) [Line Items]
Maturity date, description		The loans bear interest at various rates to be repaid over a period of three (3) years at various maturity dates.
Paycheck Protection Program Loan [Member]
Loans Payable (Details) [Line Items]
Proceeds from loans received	$ 345,000
Economic Injury Disaster Loan [Member]
Loans Payable (Details) [Line Items]
Proceeds from loans received		$ 345,000
Granted loan amount		$ 10,000

Capital Leases (Details)

Capital Leases (Details)	9 Months Ended
	Sep. 30, 2021USD ($)$ / shares
Disclosure Text Block [Abstract]
Capital lease term	60 months
Monthly payments for lease | $	$ 757
Lease price | $ / shares	$ 1

Capital Leases (Details) - Sche

Capital Leases (Details) - Schedule of maturities	Sep. 30, 2021USD ($)
Schedule of maturities [Abstract]
Capital lease	$ 10,257
Less current portion	9,088
Total long-term liabilities	$ 1,169

Assets Held For Sale (Details)

Assets Held For Sale (Details) - USD ($)	Sep. 13, 2021	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Property, Plant and Equipment Assets Held-for-sale Disclosure [Abstract]
Preferred stock fair value				$ 630,000
Amount of residential property from buyer	$ 464,000
Offer amount of residential property	50,000
Total amount of residential property	514,000	$ 514,000		514,000
Impairment of residential property	$ 116,000	$ 116,000		$ 116,000

Commitments and Contingencies (

Commitments and Contingencies (Details)	9 Months Ended
	Sep. 30, 2021USD ($)m²
Commitments and Contingencies (Details) [Line Items]
Warrant reserve	$ 20,000
Mckinney [Member]
Commitments and Contingencies (Details) [Line Items]
Area of land (in Square Meters) | m²	12,000
Base rent	$ 7,000

Subsequent Events (Details)

Subsequent Events (Details) - Subsequent Event [Member] - USD ($)	Nov. 04, 2021	Nov. 02, 2021	Nov. 02, 2021	Nov. 15, 2021	Nov. 05, 2021	Nov. 02, 2021
Subsequent Events (Details) [Line Items]
Aggregate purchase price (in Dollars)					$ 255,000
Subscription agreements, description	The Company also issued an aggregate of 1,200,000 warrants to the investors.				The Company also issued an aggregate of 2,550,000 Series A warrants (with an exercise price of $0.10), 1,020,000 Series B warrants (with an exercise price of $0.25), and 255,000 Series C warrants (with an exercise price of $1.00) to the investors.
Subsequent event, description				Between October 11, 2021 and November 15, 2021, the Company issued to consultants an aggregate of 2,312,237 shares of the Company’s common stock for services including an aggregate of 470,719 shares of common stock for settlement of prior consulting agreement.
Series U preferred stock [Member]
Subsequent Events (Details) [Line Items]
Aggregate converted shares		20				165
Aggregate shares of common stock		752,482				6,901,698
Series L Preferred Stock [Member]
Subsequent Events (Details) [Line Items]
Aggregate converted shares		50
Aggregate shares of common stock		3,358,649
Series O Preferred Stock [Member]
Subsequent Events (Details) [Line Items]
Aggregate converted shares						200
Aggregate shares of common stock						9,511,600
Series S Preferred Stock [Member]
Subsequent Events (Details) [Line Items]
Aggregate converted shares			19
Aggregate shares of common stock			471,344
Series Q Preferred Stock [Member]
Subsequent Events (Details) [Line Items]
Aggregate converted shares						105
Aggregate shares of common stock						4,395,512
Series R Preferred Stock [Member]
Subsequent Events (Details) [Line Items]
Aggregate converted shares						848
Aggregate shares of common stock						45,592,189
Series W Preferred Stock [Member]
Subsequent Events (Details) [Line Items]
Aggregate converted shares			13
Aggregate shares of common stock			517,668